UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM			10-Q


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended	April ~~2, 2021~~1, 2022


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to ______


Commission File Number:			001-35419


KAMAN CORPORATION
(Exact name of registrant as specified in its charter)


Connecticut			06-0613548
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)

1332 Blue Hills Avenue,

Bloomfield,

Connecticut

06002

(Address of principal executive offices)

(Zip Code)


(860)			243-7100
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading ~~Symbol~~Symbol(s)

Name of each exchange on which registered

Common Stock ($1 par value)

KAMN

New York Stock Exchange LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.


Yes			☒			No			☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).


Yes			☒			No			☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


			☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).


Yes			☐			No			☒


At April ~~30, 2021,~~22, 2022, there were			~~27,810,056~~27,977,507			shares of Common Stock outstanding.

PART I

Item 1. Financial Statements

CONDENSED CONSOLIDATED BALANCE SHEETS

KAMAN CORPORATION AND SUBSIDIARIES

(In thousands, except share and per share amounts) (Unaudited)


		April 2, 2021		December 31, 2020			April 1, 2022		December 31, 2021
Assets	Assets					Assets
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	120,724	$	104,377	Cash and cash equivalents	$	129,097	$	140,800
Restricted cash		0		25,121
Accounts receivable, net	Accounts receivable, net	102,328		153,806		Accounts receivable, net	68,824		73,524
Contract assets	Contract assets	114,601		108,645		Contract assets	99,360		112,354
Contract costs, current portion	Contract costs, current portion	5,050		3,511		Contract costs, current portion	841		850
Inventories	Inventories	197,303		185,072		Inventories	209,527		193,100
Income tax refunds receivable	Income tax refunds receivable	4,851		5,269		Income tax refunds receivable	14,241		13,832
Other current assets	Other current assets	12,628		12,173		Other current assets	14,506		12,083
Total current assets	Total current assets	557,485		597,974		Total current assets	536,396		546,543
Property, plant and equipment, net of accumulated depreciation of $233,534 and $228,984, respectively		207,145		210,852
Property, plant and equipment, net of accumulated depreciation of $256,512 and $251,888, respectively						Property, plant and equipment, net of accumulated depreciation of $256,512 and $251,888, respectively	197,073		197,822
Operating right-of-use assets, net	Operating right-of-use assets, net	12,048		12,880		Operating right-of-use assets, net	10,066		11,011
Goodwill	Goodwill	243,688		247,244		Goodwill	238,074		240,681
Other intangible assets, net	Other intangible assets, net	146,626		150,198		Other intangible assets, net	134,990		138,074
Deferred income taxes	Deferred income taxes	37,540		39,809		Deferred income taxes	15,601		15,717
Contract costs, noncurrent portion	Contract costs, noncurrent portion	7,205		8,311		Contract costs, noncurrent portion	10,114		10,249
Other assets	Other assets	39,000		39,125		Other assets	37,941		38,385
Total assets	Total assets	$	1,250,737	$	1,306,393	Total assets	$	1,180,255	$	1,198,482
Liabilities and Shareholders’ Equity	Liabilities and Shareholders’ Equity					Liabilities and Shareholders’ Equity
Current liabilities:	Current liabilities:					Current liabilities:
Accounts payable – trade	Accounts payable – trade	$	45,887	$	60,200	Accounts payable – trade	$	41,446	$	42,134
Accrued salaries and wages	Accrued salaries and wages	40,306		70,552		Accrued salaries and wages	27,668		38,892
Contract liabilities, current portion	Contract liabilities, current portion	32,622		39,073		Contract liabilities, current portion	2,808		2,945
Operating lease liabilities, current portion	Operating lease liabilities, current portion	4,057		4,305		Operating lease liabilities, current portion	4,333		4,502
Income taxes payable	Income taxes payable	1,203		19		Income taxes payable	443		386
Liabilities held for sale, current portion		0		18,086
Other current liabilities	Other current liabilities	35,722		36,177		Other current liabilities	35,002		32,076
Total current liabilities	Total current liabilities	159,797		228,412		Total current liabilities	111,700		120,935
Long-term debt, excluding current portion, net of debt issuance costs	Long-term debt, excluding current portion, net of debt issuance costs	186,378		185,401		Long-term debt, excluding current portion, net of debt issuance costs	197,297		189,421
Deferred income taxes	Deferred income taxes	7,205		7,381		Deferred income taxes	6,137		6,506
Underfunded pension	Underfunded pension	63,185		69,610		Underfunded pension	16,310		21,786
Contract liabilities, noncurrent portion	Contract liabilities, noncurrent portion	12,120		11,019		Contract liabilities, noncurrent portion	16,528		16,528
Operating lease liabilities, noncurrent portion	Operating lease liabilities, noncurrent portion	8,632		9,325		Operating lease liabilities, noncurrent portion	6,380		7,140
Liabilities held for sale, noncurrent portion		0		1,171
Other long-term liabilities	Other long-term liabilities	46,201		47,636		Other long-term liabilities	39,155		39,837
Commitments and contingencies (Note 14)		0		0
Commitments and contingencies (Note 15)						Commitments and contingencies (Note 15)	0		0
Shareholders' equity:	Shareholders' equity:					Shareholders' equity:
Preferred stock, $1 par value, 200,000 shares authorized; NaN outstanding		0		0
Common stock, $1 par value, 50,000,000 shares authorized; voting; 30,370,157 and 30,278,668 shares issued, respectively		30,370		30,279
Preferred stock, $1 par value, 200,000 shares authorized; none outstanding						Preferred stock, $1 par value, 200,000 shares authorized; none outstanding	—		—
Common stock, $1 par value, 50,000,000 shares authorized; voting; 30,550,123 and 30,434,269 shares issued, respectively						Common stock, $1 par value, 50,000,000 shares authorized; voting; 30,550,123 and 30,434,269 shares issued, respectively	30,550		30,434
Additional paid-in capital	Additional paid-in capital	241,444		238,829		Additional paid-in capital	238,417		248,153
Retained earnings	Retained earnings	730,913		728,764		Retained earnings	755,519		750,445
Accumulated other comprehensive income (loss)	Accumulated other comprehensive income (loss)	(114,466)		(130,821)		Accumulated other comprehensive income (loss)	(115,841)		(111,385)
Less 2,564,358 and 2,555,785 shares of common stock, respectively, held in treasury, at cost		(121,042)		(120,613)
Less 2,591,242 and 2,573,896 shares of common stock, respectively, held in treasury, at cost						Less 2,591,242 and 2,573,896 shares of common stock, respectively, held in treasury, at cost	(121,897)		(121,318)
Total shareholders’ equity	Total shareholders’ equity	767,219		746,438		Total shareholders’ equity	786,748		796,329
Total liabilities and shareholders’ equity	Total liabilities and shareholders’ equity	$	1,250,737	$	1,306,393	Total liabilities and shareholders’ equity	$	1,180,255	$	1,198,482

See accompanying notes to condensed consolidated financial statements.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

KAMAN CORPORATION AND SUBSIDIARIES

(In thousands, except per share amounts) (Unaudited)


		For the Three Months Ended					For the Three Months Ended
		April 2, 2021		April 3, 2020			April 1, 2022		April 2, 2021
Net sales	Net sales	$	171,616	$	207,322	Net sales	$	158,048	$	171,616
Cost of sales	Cost of sales	118,711		139,620		Cost of sales	107,461		118,711
Gross profit	Gross profit	52,905		67,702		Gross profit	50,587		52,905
Selling, general and administrative expenses	Selling, general and administrative expenses	44,991		60,989		Selling, general and administrative expenses	39,721		38,128
Research and development costs						Research and development costs	5,113		4,226
Intangible asset amortization expense						Intangible asset amortization expense	2,467		2,637
Costs from transition services agreement	Costs from transition services agreement	705		4,140		Costs from transition services agreement	—		705
Cost of acquired retention plans		0		5,703
Restructuring and severance costs	Restructuring and severance costs	1,352		1,795		Restructuring and severance costs	169		1,352
Loss (gain) on sale of business		234		(493)
Net loss (gain) on sale of assets		10		(10)
Operating income (loss)		5,613		(4,422)
Loss on sale of business						Loss on sale of business	—		234
Net loss on sale of assets						Net loss on sale of assets	60		10
Operating income						Operating income	3,057		5,613
Interest expense, net	Interest expense, net	4,251		3,247		Interest expense, net	2,481		4,251
Non-service pension and post retirement benefit income	Non-service pension and post retirement benefit income	(6,643)		(4,063)		Non-service pension and post retirement benefit income	(5,263)		(6,643)
Income from transition services agreement	Income from transition services agreement	(475)		(2,974)		Income from transition services agreement	—		(475)
Other expense, net	Other expense, net	289		218		Other expense, net	504		289
Earnings (loss) from continuing operations before income taxes		8,191		(850)
Income tax expense (benefit)		207		(443)
Earnings (loss) from continuing operations		7,984		(407)
Earnings from discontinued operations before gain on disposal, net of tax		0		0
Gain on disposal of discontinued operations, net of tax		0		692
Total earnings from discontinued operations		0		692
Earnings before income taxes						Earnings before income taxes	5,335		8,191
Income tax expense						Income tax expense	1,307		207
Net earnings	Net earnings	$	7,984	$	285	Net earnings	$	4,028	$	7,984

Earnings per share:	Earnings per share:					Earnings per share:
Basic earnings (loss) per share from continuing operations		$	0.29	$	(0.01)
Basic earnings per share from discontinued operations		0.00		0.02
Basic earnings per share	Basic earnings per share	$	0.29	$	0.01	Basic earnings per share	$	0.14	$	0.29
Diluted earnings (loss) per share from continuing operations		$	0.29	$	(0.01)
Diluted earnings per share from discontinued operations		0.00		0.02
Diluted earnings per share	Diluted earnings per share	$	0.29	$	0.01	Diluted earnings per share	$	0.14	$	0.29
Average shares outstanding:	Average shares outstanding:					Average shares outstanding:
Basic	Basic	27,815		27,809		Basic	27,950		27,815
Diluted	Diluted	27,867		27,891		Diluted	28,082		27,867

See accompanying notes to condensed consolidated financial statements.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

KAMAN CORPORATION AND SUBSIDIARIES

(In thousands) (Unaudited)


		For the Three Months Ended					For the Three Months Ended
		April 2, 2021		April 3, 2020			April 1, 2022		April 2, 2021
Net earnings	Net earnings	$	7,984	$	285	Net earnings	$	4,028	$	7,984
Other comprehensive income (loss), net of tax:	Other comprehensive income (loss), net of tax:					Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments and other	Foreign currency translation adjustments and other	15,513		(10,826)		Foreign currency translation adjustments and other	(5,218)		15,513
Change in pension and post-retirement benefit plan liabilities, net of tax expense of $250 and $330, respectively		842		1,107
Other comprehensive income (loss)		16,355		(9,719)
Comprehensive income (loss)		$	24,339	$	(9,434)
Change in pension and post-retirement benefit plan liabilities, net of tax expense of $228 and $250, respectively						Change in pension and post-retirement benefit plan liabilities, net of tax expense of $228 and $250, respectively	762		842
Other comprehensive (loss) income						Other comprehensive (loss) income	(4,456)		16,355
Comprehensive (loss) income						Comprehensive (loss) income	$	(428)	$	24,339

See accompanying notes to condensed consolidated financial statements.


CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS KAMAN CORPORATION AND SUBSIDIARIES (In thousands) (Unaudited)


	For the Three Months Ended
	April 1, 2022		April 2, 2021
Cash flows from operating activities:
Net earnings	$	4,028	$	7,984
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation and amortization	8,832		9,209
Amortization of debt issuance costs	442		424
Accretion of convertible notes discount	—		738
Provision for doubtful accounts	135		173
Loss on sale of business	—		234
Net loss on sale of assets	60		10
Net loss on derivative instruments	449		590
Stock compensation expense	2,081		1,743
Deferred income taxes	(1,247)		1,793
Changes in assets and liabilities, excluding effects of acquisitions/divestitures:
Accounts receivable	4,307		50,254
Contract assets	12,973		(5,704)
Contract costs	144		(432)
Inventories	(17,285)		(13,655)
Income tax refunds receivable	(410)		418
Operating right of use assets	915		799
Other assets	(2,249)		1,042
Accounts payable - trade	(612)		(14,707)
Contract liabilities	(137)		(5,439)
Operating lease liabilities	(899)		(908)
Acquired retention plan payments	—		(25,108)
Other current liabilities	(10,581)		(6,796)
Income taxes payable	53		1,173
Pension liabilities	(1,876)		(5,452)
Other long-term liabilities	(140)		(798)
Net cash used in operating activities	(1,017)		(2,415)
Cash flows from investing activities:
Proceeds from sale of business, net of cash on hand	—		(3,428)
Expenditures for property, plant & equipment	(6,877)		(4,678)
Other, net	424		6
Net cash used in investing activities	(6,453)		(8,100)
Cash flows from financing activities:
Purchase of treasury shares	(575)		(344)
Dividends paid	(5,572)		(5,545)
Other, net	2,112		1,205
Net cash used in financing activities	(4,035)		(4,684)
Net decrease in cash and cash equivalents	(11,505)		(15,199)
Effect of exchange rate changes on cash and cash equivalents	(198)		(166)
Cash and cash equivalents and restricted cash at beginning of period (See Note 3)	140,800		136,089
Cash and cash equivalents and restricted cash at end of period	$	129,097	$	120,724

For the Three Months Ended
April 2,
2021 April 3,
2020
Cash flows from operating activities:
Net earnings $ 7,984 $ 285
Less: Total earnings from discontinued operations 0 692
Earnings (loss) from continuing operations $ 7,984 $ (407)
Adjustments to reconcile net earnings from continuing operations to net cash (used in) provided by operating activities of continuing operations:
Depreciation and amortization 9,209 9,509
Amortization of debt issuance costs 424 492
Accretion of convertible notes discount 738 702
Provision for doubtful accounts 173 179
Loss (gain) on sale of business 234 (493)
Net loss (gain) on sale of assets 10 (10)
Net loss on derivative instruments 590 983
Stock compensation expense 1,743 1,633
Deferred income taxes 1,793 3,493
Changes in assets and liabilities, excluding effects of acquisitions/divestitures:
Accounts receivable 50,254 (6,531)
Contract assets (5,704) (11,665)
Contract costs (432) (709)
Inventories (13,655) (25,206)
Income tax refunds receivable 418 (2,078)
Operating right of use assets 799 1,223
Other assets 1,042 (917)
Accounts payable - trade (14,707) (6,405)
Contract liabilities (5,439) 1,743
Operating lease liabilities (908) (1,183)
Acquired retention plan payments (25,108) 0
Other current liabilities (6,796) (8,079)
Income taxes payable 1,173 (1,038)
Pension liabilities (5,452) (12,887)
Other long-term liabilities (798) 2,209
Net cash used in operating activities of continuing operations (2,415) (55,442)
Net cash used in operating activities of discontinued operations 0 0
Net cash used in operating activities (2,415) (55,442)
Cash flows from investing activities:
Proceeds from sale of assets 54 11
Proceeds from sale of discontinued operations 0 5,223
Proceeds from sale of business, net of cash on hand (3,428) 493
Expenditures for property, plant & equipment (4,678) (5,559)
Acquisition of businesses, net of cash acquired 0 (304,342)
Other, net (48) 394
Net cash used in investing activities of continuing operations (8,100) (303,780)
Net cash used in investing activities of discontinued operations 0 0
Net cash used in investing activities (8,100) (303,780)
Cash flows from financing activities:
Net borrowings under revolving credit agreements 0 201,100
Net change in bank overdraft 797 371
Proceeds from exercise of employee stock awards 880 1,455
Purchase of treasury shares (344) (14,072)
Dividends paid (5,545) (5,595)
Other, net (472) (381)
Net cash (used in) provided by financing activities of continuing operations (4,684) 182,878
Net cash provided by financing activities of discontinued operations 0 0
Net cash (used in) provided by financing activities (4,684) 182,878
Net decrease in cash and cash equivalents (15,199) (176,344)
Effect of exchange rate changes on cash and cash equivalents (166) 262
Cash and cash equivalents and restricted cash at beginning of period (See Note 3) 136,089 471,540
Cash and cash equivalents and restricted cash at end of period $ 120,724 $ 295,458

See accompanying notes to condensed consolidated financial statements.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three-month fiscal periods ended April ~~2, 2021~~1, 2022 and April ~~3, 2020~~2, 2021

(Unaudited)

1. BASIS OF PRESENTATION

During the third quarter of 2019, Kaman Corporation ("the Company") completed the sale of its Distribution business for total cash consideration of approximately $700.0 million, excluding certain working capital adjustments which were finalized in the first quarter of 2020 and transaction costs. The finalization of the gain onFollowing the sale of the Company's Distribution business ~~was recorded~~in 2019, the Company operated as one segment. In the fourth quarter of 2021, our Chief Operating Decision Maker ("CODM") established a new structure for the Company to ~~gain on disposal of discontinued operations, net of tax on~~better align the Company's ~~Condensed Consolidated Statements~~businesses to support capital allocation plans, portfolio management and growth. This new structure resulted in the introduction of ~~Operations in~~three reportable segments: Engineered Products, Precision Products and Structures. See Note 5, Revenue and Segment Information, for 2022 financial results by segment and a recast of financial results by segment for the three-month fiscal period ended April ~~3, 2020. See Note 3,~~ ~~Disposals, to the Condensed Consolidated Financial Statements for further information.~~

~~During the fourth quarter of 2020, the Company committed to a plan and received approval from its Board of Directors to sell~~

its United Kingdom ("UK") Composites division. As a result of the approved plan, the UK Composites division met the criteria set forth in ASC 205-20 for held for sale. At December 31, 2020, the assets of the UK Composites business were considered impaired as the estimated fair value of the disposal group was lower than the estimated carrying value of the UK Composites business. As a result, the assets of the UK Composites business were written off and the remaining loss related to the anticipated sale of the disposal group was accrued for in liabilities held for sale, current portion on the Company's Consolidated Balance Sheets. The related liabilities of the UK division to be sold were reclassified to liabilities held for sale, respectively, as of December 31, 2020 on the Company's Consolidated Balance Sheets. On February 2, ~~2021, the Company sold its UK Composites business. See Note 3,~~ ~~Discontinued Operations and Liabilities Held for Sale, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 ("2020 Form 10-K") for additional information.~~2021.

In the opinion of management, the condensed consolidated financial information reflects all adjustments necessary for a fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented, but do not include all disclosures required by accounting principles generally accepted in the United States of America ("GAAP"). All such adjustments are of a normal recurring nature, unless otherwise disclosed in this report. Certain amounts in prior year financial statements and notes thereto have been reclassified to conform to current year presentation. The statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s ~~2020~~Annual Report on Form ~~10-K.~~10-K for the year ended December 31, 2021.

The Company has a calendar year-end; however, its first three fiscal quarters follow a 13-week convention, with each quarter ending on a Friday. The first quarters for ~~2021~~2022 and ~~2020~~2021 ended on April ~~2, 2021,~~1, 2022, and April ~~3, 2020,~~2, 2021, respectively.

2. RECENT ACCOUNTING STANDARDS

Recent Accounting Standards Adopted

In ~~December 2019,~~May 2021, the Financial Accounting Standards Board ("FASB") issued Accounting ~~Standards~~Standard Update ("ASU") ~~2019-12, "Income Taxes~~2021-04, "Earnings Per Share (Topic ~~740)~~260), Debt - ~~Simplifying the~~Modifications and Extinguishments (Subtopic 470-50), Compensation - Stock Compensation (Topic 718), and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Issuer's Accounting for ~~Income Taxes"~~Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force)". The objective of ~~the~~this standard update is to ~~simplify the~~clarify and reduce diversity in an issuer's accounting for ~~income taxes by removing certain exceptions~~modifications or exchanges of freestanding equity-classified written call options that remain equity classified after modification or exchange. The guidance clarifies whether an issuer should account for a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as either an adjustment to equity and, ~~to improve consistent application~~if so, the related earnings per share ("EPS") effects, if any, or as an expense and, if so, the manner and pattern of ~~Topic 740 by clarifying and amending existing guidance.~~recognition. The standard update is effective for fiscal years ~~and~~beginning after December 15, 2021, including interim periods within those fiscal ~~years, beginning after December 15, 2020.~~years. Early adoption ~~of the standard is~~was permitted, including adoption in ~~any interim period for which financial statements have not yet been issued. If early adopted in~~ an interim ~~period, the adjustments should be reflected as of the beginning of the annual period that includes that interim~~ period. ~~All amendments under the standard must be adopted in the same period. In 2021, the~~The Company adopted ~~ASU 2019-12 using~~this standard on January 1, 2022. The adoption of this standard update did not have a material impact on the ~~modified retrospective basis which resulted in a cumulative effect reduction to retained earnings of $0.3 million.~~Company's consolidated financial statements.

In August 2020, the FASB issued ASU 2020-06, "Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity". The objective of this standard update is to simplify the accounting for certain financial instruments with characteristics of liabilities and equity. The update removes certain separation models between a debt component and equity or derivative component for certain convertible ~~instruments,~~instruments. Entities that previously required separate accounting for conversion features will report less interest expense as those conversion features were recorded as debt discounts which were amortized over the term of the debt. In addition, this ASU adds new disclosure requirements for convertible instruments to improve the decision usefulness and relevance of the information being provided to users of financial statements, clarifies the guidance for determining whether a contract qualifies for a scope exception from derivative accounting, and ~~amends~~requires the application of the if-converted method when calculating diluted EPS guidance to improve consistency. The standard update is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021. Early adoption of the standard iswas permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. An entity should adopt the guidance as of the beginning of its annual fiscal year and can do so using a modified retrospective method or fully retrospective method of transition. On January 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective basis which resulted in a cumulative effect adjustment to the opening balance sheet. The ~~Company is currently assessing the potential impact this standard update could have on its~~prior period condensed consolidated financial ~~statements.~~statements have not been retroactively adjusted and continue to be reported under the accounting standard in effect for the period.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April ~~2, 2021~~1, 2022 and April ~~3, 2020~~2, 2021

(Unaudited)

2. RECENT ACCOUNTING STANDARDS (CONTINUED)

Recent Accounting Standards Adopted - continued

The cumulative effect of the adjustments recorded to the opening balance sheet on January 1, 2022 for the adoption of ASU 2020-06 was as follows:


in thousands	Balance at December 31, 2021		Adjustments due to ASU 2020-06		Balance at January 1, 2022
Assets
Deferred income taxes	$	15,717	$	1,770	$	17,487

Liabilities
Long-term debt, excluding current portion, net of debt issuance costs	$	189,421	$	7,624	$	197,045

Equity
Additional paid-in capital	$	248,153	$	(12,489)	$	235,664
Retained earnings	750,445		6,635		757,080

Beginning in 2022, the Company will calculate diluted EPS using the if-converted method for its convertible debt instruments, which is not expected to have a material impact on the consolidated results. Historically, the Company used the treasury stock method to calculate diluted EPS for its convertible debt instruments. In the first quarter of 2022, there was no impact as diluted EPS calculated to $0.14 using both the if-converted method and treasury stock method.

Refer to Note 13, Debt, for further information on the Company's convertible notes.

Recent Accounting Standards Yet to be Adopted

In March 2022, the FASB issued ASU 2022-01, "Derivatives and Hedging (Topic 815): Fair Value Hedging-Portfolio Layer Method". The amendments in this standard update expand the current last-of-layer method of hedge accounting that permits only one hedged layer to allow multiple hedged layers of a single closed portfolio. This standard update is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted on any date on or after the issuance of this update for any entity that has adopted the amendments in ASU 2017-12 for the corresponding period. If an entity adopts the amendments in an interim period, the effect of adopting the amendments related to basis adjustments should be reflected as of the beginning of the fiscal year of adoption. The adoption of this standard update is not expected to have a material impact on the Company's consolidated financial statements; however, the impact will be dependent on future hedging activity.

In October 2021, the FASB issued ASU 2021-08, "Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers". The amendments in this standard update address diversity and inconsistency related to the recognition and measurement of contract assets and contract liabilities acquired in a business combination and require that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. This standard update is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption of the standard is permitted, including adoption in an interim period. The adoption of this standard update is not expected to have a material impact on the Company's consolidated financial statements; however, the impact will be dependent on future business combinations.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April 1, 2022 and April 2, 2021

(Unaudited)

2. RECENT ACCOUNTING STANDARDS (CONTINUED)

Recent Accounting Standards Yet to be Adopted - continued

In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting". The objective of the standard is to address operational challenges likely to arise in accounting for contract modifications and hedge accounting due to reference rate reform. The amendments in this ASU provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The standard update is effective for all entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments for contract modifications by topic or industry subtopic as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020. Once elected for a topic or industry subtopic, the amendments in this standard update must be applied prospectively for all eligible contract modifications for that topic or industry subtopic. An entity may elect to apply the amendments for eligible hedging relationships existing as of the beginning of the interim period that includes March 12, 2020 and to new eligible hedging relationships entered into after the beginning of the interim period that includes March 12, 2020. If an entity elects to apply any of the amendments for an eligible hedging relationship existing as of the beginning of the interim period that includes March 12, 2020, any adjustments as a result of those elections must be reflected as of the beginning of that interim period. If an entity elects to apply any of the amendments for a new hedging relationship entered into between the beginning of the interim period that includes March 12, 2020 and March 12, 2020, any adjustments as a result of those elections must be reflected as of the beginning of the hedging relationship. In December 2021, the Company amended its credit agreement to move its LIBOR benchmark for non-USD borrowings to other non-USD benchmark rates. Future USD borrowings under this current Credit Agreement will continue be based on LIBOR. The impact of the adoption of this standard update is dependent on the Company's contracts modifications as a result of reference rate reform; however, the Company does not expect the adoption of the amendments associated with hedging relationships to have a material impact on the Company's consolidated financial statements.

Subsequent to the issuance of ASU 2020-04, the FASB issued the following update: ASU 2021-01, "Reference Rate Reform (Topic 848) - Scope". The amendments in this update affect the guidance within ASU 2020-04 and are being assessed with ASU 2020-04.

3. DISPOSALS

UK Composites Business

In the fourth quarter of 2020, the Company received approval from its Board of Directors to sell its UKUnited Kingdom ("UK") Composites division. ~~The Company sold its UK Composites division in a transaction that closed on February 2, 2021.~~ The sale of the UK Composites business did not meet the criteria set forth in ~~Accounting Standards Codification ("ASC")~~ASC 205-20~~, Presentation of Financial Statements - Discontinued Operations~~, for discontinued operations as it ~~does~~did not reflect a significant shift in the Company's strategy. As a result of the approved plan, the UK Composites division met the criteria set forth in ASC 205-20 for held for sale presentation at December 31, 2020. At December 31, 2020, the assets of the UK Composites business were considered impaired as the estimated fair value of the disposal group was lower than the estimated carrying value of the UK Composites business. As such, the assets of the UK Composites business were written off and the related liabilities of the UK division to be sold were reclassified to liabilities held for sale, as of December 31, 2020 on the Company's Consolidated Balance Sheets.

The ~~following table provides information~~Company recorded an impairment loss of $36.3 million in the year ended December 31, 2020. The Company sold its UK Composites division in a transaction that closed on February 2, 2021. In the three-month fiscal period ended April 2, 2021, when the sale was finalized, the Company recorded an additional loss ~~recorded~~of $0.2 million, resulting in a total loss on the sale of the UK Composites ~~business. These amounts reflect the balance sheet~~business of ~~the UK Composites business as of February 2, 2021.~~


~~In thousands~~
~~Proceeds received from the sale of the UK Composites business~~	$	~~3,600~~

~~Assets, including cash on hand~~	~~23,460~~
~~Liabilities~~	~~6,618~~
~~Net book value of business~~	~~16,842~~

~~UK cumulative foreign currency translation adjustment balance~~	~~22,835~~

~~Transaction costs~~	~~442~~

~~Loss on the sale of the UK Composites business~~	$	~~36,519~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~For the three-month fiscal periods ended April 2, 2021 and April 3, 2020~~

~~(Unaudited)~~

~~3. DISPOSALS (CONTINUED)~~

~~UK Composites Business - continued~~

~~Of this amount, a loss of $36.3 million was recorded in the year ended December 31, 2020 and a loss of $0.2 million was recorded in the three-month fiscal period ended April 2, 2021.~~$36.5 million.

Cash and cash equivalents and restricted cash at the beginning of the period on the Company's Condensed Consolidated Statement of Cash Flows for the three-month fiscal period ended April 2, 2021 ~~includes~~included $6.6 million of cash that was included in the UK Composites business disposal group. Given the assets of the disposal group were recognized net of the impairment recorded in the year ended December 31, 2020, such amounts were not reflected on the Company's Condensed Consolidated Balance Sheet at December 31, 2020.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April 1, 2022 and April 2, 2021

(Unaudited)

3. DISPOSALS (CONTINUED)

Distribution Business

On August 26, 2019, the Company completed the sale of its Distribution business for total cash consideration of approximately $700.0 million, excluding certain working capital adjustments which were finalized in the first quarter of 2020. The sale of the Distribution business was a result of the Company's shift in strategy to be a highly focused, technologically differentiated aerospace and engineered products company. As a result of the sale, the Distribution business met the criteria set forth in ASC 205-20 for discontinued operations.

business. Upon closing, the Company entered into a transition services agreement ("TSA") with the buyer, pursuant to which the Company agreed to support the information technology ("IT"), human resources and benefits, tax and treasury functions of the Distribution business for six to twelve months. The buyer exercised ~~the~~an option to extend the support period for up to ~~a maximum of an~~one additional year for certain IT services. ~~The buyer has~~During the ~~right to terminate individual services at any point over~~third quarter of 2021, the ~~renewal term~~TSA expired and ~~began to terminate certain services in 2020. Substantially~~ all services were completed as of the end of the first quarter of 2021; however, the TSA is expected to be fully completed by the third quarter of 2021. Since the sale of the Distribution business, costs associated with the TSA were $17.9 million through April 2, 2021. The Company incurred $0.7 million and $4.1 million in costsperiod. As such, there was no activity associated with the TSA in 2022. Through the term of the TSA, the Company incurred $18.9 million in costs and earned $13.0 million in income associated with the TSA. Of these amounts, $0.7 million in costs were incurred and $0.5 million in income was earned in three-month fiscal ~~periods~~period ended April 2, ~~2021 and April 3, 2020, respectively.~~2021. These amounts were included in costs from transition services agreement and income from transition services agreement on the Company's Condensed Consolidated Statements of Operations. Since the sale of the Distribution business, the Company earned $12.6 million in income associated with the TSA through April 2, 2021. The Company earned $0.5 million and $3.0 million in income associated with the TSA in the three-month fiscal periods ended April 2, 2021 and April 3, 2020,Operations, respectively. ~~These amounts were included in income from transition services on the Company's Condensed Consolidated Statements of Operations.~~

Since the sale of the Distribution business, cash outflows from the Company to its former Distribution business totaled ~~$8.1~~$8.7 million through April ~~2, 2021,~~1, 2022, which primarily related to Distribution employee and employee-related costs incurred prior to the sale. There were 0no cash flows from the Company to its former Distribution business in the three-month fiscal ~~period~~periods ended April 1, 2022 and April 2, 2021. ~~Cash outflows from the Company to its former Distribution business after the sale totaled $0.3 million for the three-month fiscal period ended April 3, 2020.~~ Since the sale of the Distribution business, cash inflows from the Company's former Distribution business to the Company totaled ~~$17.4~~$18.9 million through April ~~2, 2021,~~1, 2022, which primarily related to cash received for services performed under the TSA and the $5.2 million working capital adjustment settled in the first quarter of 2020. Cash inflows from the Company's former Distribution business received in the three-month fiscal ~~periods~~period ended April 2, 2021 ~~and April 3, 2020~~ totaled $0.5 ~~million and $7.9 million, respectively.~~million. Cash inflows from the former Distribution business were not material in 2022.

In the three-month fiscal period ended April 3, 2020, the Company recorded a pretax gain on disposal of discontinued operations as a result of the final settlement of the working capital adjustment, partially offset by transaction costs. The pretax gain of $0.9 million was subject to income tax expense of $0.2 million, resulting in a gain on disposal of discontinued operations, net of tax of $0.7 million in the three-month fiscal period ended April 3, 2020 which was included in the Company's Condensed Consolidated Statement of Operations. As the gain on the sale of the Distribution business was finalized in 2020, no activity aside from the TSA activity and cash flows discussed above impacted the Company's Condensed Consolidated Financial Statements in the three-month fiscal period ended April 2, 2021.

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~For the three-month fiscal periods ended April 2, 2021 and April 3, 2020~~

~~(Unaudited)~~

4. BUSINESS COMBINATIONS

On January 3, 2020, the Company acquired all of the equity interests of Bal Seal Engineering ("Bal Seal"), of Foothill Ranch, California, at a purchase price of $317.5 million. ~~Bal Seal is~~ a leader in the design, development, and manufacturing of highly engineered products, including precision springs, seals, and contacts. With this acquisition, the Company has significantly expanded its portfolio of engineered products and offerings while creating new opportunities to reach customers in medical technology, aerospace and defense, and industrial end markets.

Upon closing, the Company funded $24.7 million associated with employee retention plans at Bal Seal. This amount and related interest was included in restricted cash on the Company's Consolidated Balance Sheets as of December 31, 2020. Eligible participants received an allocation of the escrow balance one year following the acquisition date, which was reflected in the Company's cash flows from operating activities for the three-month fiscal period ended April 2, 2021.

5. REVENUE AND SEGMENT INFORMATION

The Company is organized based upon the nature of its products and services, and is composed of three operating segments, each overseen by a segment manager. These segments are reflective of how the Company’s Chief Executive Officer, who is its CODM, reviews operating results for the purposes of allocating resources and assessing performance. The Company has not aggregated operating segments for purposes of identifying reportable segments.

The Engineered Products segment serves the aerospace and defense, industrial and medical markets providing sophisticated proprietary aircraft bearings and components; super precision, miniature ball bearings; and proprietary spring energized seals, springs and contacts.

The Precision Products segment serves the aerospace and defense markets providing precision safe and arming solutions for missile and bomb systems for the U.S. and allied militaries; subcontract helicopter work; restoration, modification and support of the Company's SH-2G Super Seasprite maritime helicopters; manufacture and support of the heavy lift K-MAX® manned helicopter, the K-MAX TITAN unmanned aerial system and the KARGO UAV unmanned aerial system, a purpose built autonomous medium lift logistics vehicle.

The Structures segment serves the aerospace and defense and medical end markets providing sophisticated complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing aircraft, and medical imaging solutions.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April 1, 2022 and April 2, 2021

(Unaudited)

5. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Summarized financial information by business segment is as follows:


	For the Three Months Ended
	April 1, 2022		April 2, 2021
In thousands
Net sales:
Engineered Products	$	81,452	$	71,779
Precision Products	47,549		60,533
Structures	29,047		39,304
Net sales	$	158,048	$	171,616
Operating income (loss):
Engineered Products	$	11,042	$	4,906
Precision Products	3,409		13,053
Structures	(617)		320
Corporate expense	(10,548)		(10,365)
Other unallocated expenses, net(1)	(229)		(2,301)
Operating income	$	3,057	$	5,613

(1) Other unallocated expenses, net include costs from the TSA, restructuring and severance costs, loss on sale of business, and net loss on sale of assets.

Disaggregation of Revenue

The following table disaggregates ~~total~~segment revenue by major product ~~sales by end market.~~line:


							For the Three Months Ended
		For the Three Months Ended					April 1, 2022
		April 2, 2021		April 3, 2020			Engineered Products		Precision Products		Structures		Total
In thousands	In thousands					In thousands
Defense	Defense	$	43,611	$	48,757	Defense	$	9,653	$	5,322	$	16,255	$	31,230
Safe and Arm Devices	Safe and Arm Devices	41,586		58,000		Safe and Arm Devices	—		37,322		—		37,322
Commercial, Business, & General Aviation		47,958		63,257
Commercial, Business & General Aviation						Commercial, Business & General Aviation	32,378		3,767		10,813		46,958
Medical	Medical	20,583		20,976		Medical	21,149		—		1,979		23,128
Industrial & Other	Industrial & Other	17,878		16,332		Industrial & Other	18,272		1,138		—		19,410
Total revenue	Total revenue	$	171,616	$	207,322	Total revenue	$	81,452	$	47,549	$	29,047	$	158,048

							For the Three Months Ended
							April 2, 2021
							Engineered Products		Precision Products		Structures		Total
In thousands						In thousands
Defense						Defense	$	11,228	$	6,994	$	25,389	$	43,611
Safe and Arm Devices						Safe and Arm Devices	—		41,586		—		41,586
Commercial, Business & General Aviation						Commercial, Business & General Aviation	25,072		10,902		11,984		47,958
Medical						Medical	18,652		—		1,931		20,583
Industrial & Other						Industrial & Other	16,827		1,051		—		17,878
Total revenue						Total revenue	$	71,779	$	60,533	$	39,304	$	171,616

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April 1, 2022 and April 2, 2021

(Unaudited)

5. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Disaggregation of Revenue - continued

COVID-19

The impact of the novel coronavirus (“COVID-19”) and the precautionary measures instituted by governments and businesses to mitigate the spread, including limiting non-essential ~~gatherings of people, ceasing all non-essential~~ travel, ~~ordering certain businesses and government agencies to cease non-essential operations at physical locations and issuing “shelter-in-place” orders,~~ have contributed to a general slowdown in the global ~~economy and significant volatility in financial markets.~~economy. The Company has implemented strategies to limit the risk to its operations with a continued focus on the health of its employees and the satisfaction of its customers’ requirements. Despite all of these efforts to mitigate the risks associated with COVID-19, the effects of the pandemic have adversely impacted our commercial end markets, more specifically Commercial, Business and General Aviation customers. ~~The Company saw~~Management is encouraged by the recoveries for these products and the strong order intake seen in the ~~medical and industrial end markets during the~~ first ~~quarter~~three months of 2021 and management expects improved performance through the remainder of 2021. As of the date of this filing, the Company's defense and safe and arm device end markets have not been impacted by COVID-19.2022. The extent and duration of time to which COVID-19 may adversely impact the Company depends on future developments, which ~~are highly~~continue to be uncertain and ~~unpredictable at this time.~~unpredictable.

The following table disaggregates total revenue by product types.


		For the Three Months Ended					For the Three Months Ended
		April 2, 2021		April 3, 2020			April 1, 2022
							Engineered Products		Precision Products		Structures		Total
Original Equipment Manufacturer	Original Equipment Manufacturer	63	%	61	%	Original Equipment Manufacturer	41	%	2	%	18	%	61	%
Aftermarket	Aftermarket	13	%	11	%	Aftermarket	11	%	4	%	—	%	15	%
Safe and Arm Devices	Safe and Arm Devices	24	%	28	%	Safe and Arm Devices	—	%	24	%	—	%	24	%
Total revenue	Total revenue	100	%	100	%	Total revenue	52	%	30	%	18	%	100	%

							For the Three Months Ended
							April 2, 2021
							Engineered Products		Precision Products		Structures		Total
Original Equipment Manufacturer						Original Equipment Manufacturer	32	%	8	%	23	%	63	%
Aftermarket						Aftermarket	10	%	3	%	—	%	13	%
Safe and Arm Devices						Safe and Arm Devices	—	%	24	%	—	%	24	%
Total revenue						Total revenue	42	%	35	%	23	%	100	%

Disaggregation of Research and Development Costs

The following table presents research and development costs by segment:


	For the Three Months Ended
	April 1, 2022		April 2, 2021
In thousands
Engineered Products	$	2,243	$	2,822
Precision Products	2,803		1,402
Structures	67		2
Total research and development costs	$	5,113	$	4,226

911

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April ~~2, 2021~~1, 2022 and April ~~3, 2020~~2, 2021

(Unaudited)

5. REVENUE AND SEGMENT INFORMATION (CONTINUED)

~~Disaggregation of Revenue - continued~~

The following table illustrates the approximate percentage of revenue recognized for performance obligations satisfied over time versus the amount of revenue recognized for performance obligations satisfied at a point in time:

For the Three Months Ended
April 2,
2021 April 3,
2020
Over time 35 % 32 %
Point-in-time 65 % 68 %
Total revenue 100 % 100 %
Other

For contracts in which revenue is recognized over time, the Company performs detailed quarterly reviews of the progress and execution of its performance obligations under these contracts. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and opportunities and the related changes in estimates of revenues and costs. The risks and opportunities include management's judgment about the ability and cost to achieve the schedule (e.g., the number and type of milestone events), technical requirements (e.g., a newly-developed product versus a mature product) and other contract requirements. Management must make assumptions and estimates regarding labor productivity and availability, the complexity of the work to be performed, the availability of materials, the length of time to complete the performance obligation (e.g., to estimate increases in wages and prices for materials and related support cost allocations), execution by subcontractors, the availability and timing of funding from customers and overhead cost rates, among other variables. Based upon these reviews, the Company will record the effects of adjustments in profit estimates each period. If at any time management determines that in the case of a particular contract total costs will exceed total contract revenue, a provision for the entire anticipated contract loss is recorded at that time.

Net changes in revenue associated with cost growth on the Company's over time contracts were as follows:


		For the Three Months Ended					For the Three Months Ended
		April 2, 2021		April 3, 2020			April 1, 2022		April 2, 2021
In thousands	In thousands					In thousands
Net change in revenue due to change in profit estimates	Net change in revenue due to change in profit estimates	$	2,865	$	(1,115)	Net change in revenue due to change in profit estimates	$	905	$	2,865

~~The net increase in revenue in~~In the three-month fiscal ~~period~~periods ended April 1, 2022 and April 2, 2021, ~~was~~the net increases in revenue were primarily related to favorable cost performance on the joint programmable fuze ("JPF") contract with the U.S. Government ("USG"), partially offset by cost growth on certain structures programs and ~~legacy fuzing contracts. The net reduction in revenue in the three-month fiscal period ended April 3, 2020 was primarily related to cost growth on a structures program and certain~~ legacy fuzing contracts.

Unfulfilled Performance Obligations

Unfulfilled performance obligations ("backlog") represents the transaction price of firm orders for which work has not been performed and excludes unexercised contract options and potential orders under ordering-type contracts. Backlog at April ~~2, 2021~~1, 2022 and December 31, ~~2020,~~2021, and the portion of backlog the Company expects to recognize revenue on over the next twelve months is as follows:


		April 2, 2021(1)		December 31, 2020			April 1, 2022(1)		December 31, 2021
In thousands	In thousands					In thousands
Backlog	Backlog	$	562,407	$	631,236	Backlog	$	705,023	$	700,923

(1) The Company expects to recognize revenue on approximately ~~72%~~62% of backlog as of April ~~2, 2021~~1, 2022 over the next twelve months.

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~For the three-month fiscal periods ended April 2, 2021 and April 3, 2020~~

~~(Unaudited)~~

6. RESTRUCTURING AND SEVERANCE COSTS

Cost Reduction Initiative

The Company continues to evaluate its cost structure with the objective of a lean organizational structure that improves operational efficiency and provides a scalable infrastructure which facilitates future growth opportunities. We have identified workforce reductions and other reductions in certain general and administrative expenses to support the cost savings initiative. In the three-month fiscal ~~period~~periods ended April 1, 2022 and April 2, 2021, the Company incurred $0.2 million and $1.4 million in severance costs associated with these cost reduction efforts, which were included in restructuring and severance costs on the Company's Condensed Consolidated Statements of Operations.

Following the sale of the Company's former Distribution business, the Company announced it would undertake a comprehensive review of its general and administrative functions in order to improve operational efficiency and to align the Company's costs with its revenues. The objective of the initiative is to ensure that the Company has a lean organizational structure that provides a scalable infrastructure that facilitates future growth opportunities. The Company identified information technology functions to be outsourced, workforce reductions and other reductions in certain general and administrative expenses which were completed in 2020 to support the cost savings initiative discussed above. In accordance with ASC 712-10,
~~Compensation~~

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - ~~Nonretirement Postemployment Benefits, the Company recorded $1.3 million in severance costs associated with these workforce reductions in~~Continued

For the three-month fiscal ~~period~~periods ended April ~~3, 2020, which were included in restructuring~~1, 2022 and ~~severance costs on the Company's Condensed Consolidated Statements of Operations.~~April 2, 2021

(Unaudited)

In addition to the severance associated with the cost savings initiative discussed above, the Company incurred $0.5 million in severance costs as it integrated the acquisition of Bal Seal in the three-month fiscal period ended April 3, 2020.

7. ACCOUNTS RECEIVABLE, NET

Accounts receivable, net consisted of the following:


		April 2, 2021		December 31, 2020			April 1, 2022		December 31, 2021
In thousands	In thousands					In thousands
Trade receivables	Trade receivables	$	22,353	$	19,945	Trade receivables	$	24,239	$	19,228
U.S. Government contracts:	U.S. Government contracts:					U.S. Government contracts:
Billed	Billed	18,106		18,854		Billed	13,386		14,748
Cost and accrued profit - not billed	Cost and accrued profit - not billed	905		1,080		Cost and accrued profit - not billed	149		167
Commercial and other government contracts	Commercial and other government contracts					Commercial and other government contracts
Billed	Billed	58,428		111,794		Billed	31,486		36,787
Cost and accrued profit - not billed	Cost and accrued profit - not billed	4,141		4,141		Cost and accrued profit - not billed	900		4,141
Less allowance for doubtful accounts	Less allowance for doubtful accounts	(1,605)		(2,008)		Less allowance for doubtful accounts	(1,336)		(1,547)
Accounts receivable, net	Accounts receivable, net	$	102,328	$	153,806	Accounts receivable, net	$	68,824	$	73,524

The Company performs ongoing evaluations of its customers’ current creditworthiness, as determined by the review of their credit information, to determine if events have occurred subsequent to the recognition of revenue and the related receivable that provide evidence that such receivable will be realized in an amount less than that recognized at the time of sale. Estimates of credit losses are based on historical losses, current economic conditions, geographic considerations, and in some cases, evaluating specific customer accounts for risk of loss.

The following table summarizes the activity in the allowance for doubtful accounts in the three-month fiscal period ended April ~~2, 2021:~~1, 2022:


In thousands
Balance at December 31, ~~2020~~2021	$	~~(2,008)~~(1,547)
Provision	~~(173)~~(135)
Amounts written off	~~301~~137
Recoveries	~~273~~208
Changes in foreign currency exchange rates	21
Balance at April ~~2, 2021~~1, 2022	$	~~(1,605)~~(1,336)

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~For the three-month fiscal periods ended April 2, 2021 and April 3, 2020~~

~~(Unaudited)~~

~~7. ACCOUNTS RECEIVABLE, NET (CONTINUED)~~

~~COVID-19~~

The Company anticipates that the disruptions and delays resulting from the spread of COVID-19 and the measures instituted by the governments and businesses to mitigate its spread could impact the Company's liquidity in the next twelve months. The Company continues to closely monitor the collectability of its receivables from commercial aerospace customers as it recognizes there may be delays in payments due to the impacts of COVID-19 on its customers. As of the date of this filing, the Company does not believe there has been any material impact on the collectability of these receivables.

Accounts receivable, net includes amounts for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs. These amounts are as follows:


		April 2, 2021		December 31, 2020			April 1, 2022		December 31, 2021
In thousands	In thousands					In thousands
Contract changes, negotiated settlements and claims for unanticipated contract costs	Contract changes, negotiated settlements and claims for unanticipated contract costs	$	900	$	900	Contract changes, negotiated settlements and claims for unanticipated contract costs	$	900	$	900

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April 1, 2022 and April 2, 2021

(Unaudited)

8. CONTRACT ASSETS, CONTRACT COSTS AND CONTRACT LIABILITIES

Activity related to contract assets, contract costs and contract liabilities was as follows:


		April 2, 2021		December 31, 2020		$ Change		% Change			April 1, 2022		December 31, 2021		$ Change		% Change
In thousands	In thousands									In thousands
Contract assets	Contract assets	$	114,601	$	108,645	$	5,956	5.5	%	Contract assets	$	99,360	$	112,354	$	(12,994)	(11.6)	%

Contract costs, current portion	Contract costs, current portion	$	5,050	$	3,511	$	1,539	43.8	%	Contract costs, current portion	$	841	$	850	$	(9)	(1.1)	%
Contract costs, noncurrent portion	Contract costs, noncurrent portion	$	7,205	$	8,311	$	(1,106)	(13.3)	%	Contract costs, noncurrent portion	$	10,114	$	10,249	$	(135)	(1.3)	%

Contract liabilities, current portion	Contract liabilities, current portion	$	32,622	$	39,073	$	(6,451)	(16.5)	%	Contract liabilities, current portion	$	2,808	$	2,945	$	(137)	(4.7)	%
Contract liabilities, noncurrent portion	Contract liabilities, noncurrent portion	$	12,120	$	11,019	$	1,101	10.0	%	Contract liabilities, noncurrent portion	$	16,528	$	16,528	$	—	—	%

Contract Assets

The ~~increase~~decrease in contract assets was primarily due to higher amounts billed in the current period compared to the recognition of revenue related to the satisfaction or partial satisfaction of performance obligations ~~during the three-month fiscal period ended April 2, 2021. This increase was primarily related to~~for work performed and not yet billed on the ~~A-10~~JPF program, the KAflex® program and certain ~~fuzing programs, partially offset by amounts billed on the JPF program with the USG.~~structures programs. There were 0no significant impairment losses related to the Company's contract assets during the three-month fiscal periods ended April ~~2, 2021~~1, 2022 and April ~~3, 2020.~~2, 2021.

Contract assets includes amounts for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs. These amounts were as follows:


		April 2, 2021		December 31, 2020			April 1, 2022		December 31, 2021
In thousands	In thousands					In thousands
Contract changes, negotiated settlements and claims for unanticipated contract costs	Contract changes, negotiated settlements and claims for unanticipated contract costs	$	3,184	$	3,178	Contract changes, negotiated settlements and claims for unanticipated contract costs	$	695	$	682

Contract Costs

At April 2,1, 2022 and December 31, 2021, costs to fulfill a contract ~~and costs to obtain a contract~~ were ~~$10.3~~$11.0 million and ~~$2.0 million, respectively. At December 31, 2020, costs to fulfill a contract and costs to obtain a contract were $9.3 million and $2.5~~$11.1 million, respectively. These amounts ~~are~~were included in contract costs, current portion and contract costs, noncurrent portion on the Company's Condensed Consolidated Balance Sheets at April ~~2, 2021~~1, 2022 and December 31, ~~2020.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~For the three-month fiscal periods ended~~2021. There were no costs to obtain a contract at April ~~2, 2021~~1, 2022 and ~~April 3, 2020~~

~~(Unaudited)~~

~~8. CONTRACT ASSETS, CONTRACT COSTS AND CONTRACT LIABILITIES (CONTINUED)~~December 31, 2021.

Contract ~~Costs - continued~~

~~The increase in contract~~ costs, current portion at April 1, 2022 remained relatively flat compared to the balance at December 31, 2021. This was primarily attributable to the ~~addition~~amortization of contract costs, ~~to fulfill the K-MAX® program and~~mostly offset by the reclassification of a portion of costs to fulfill ~~the K-MAX® program and~~ certain structures programs from contract costs, noncurrent ~~portion, partially offset by the amortization of contract costs.~~portion. For the three-month fiscal periods ended April ~~2, 2021~~1, 2022 and April ~~3, 2020,~~2, 2021, amortization of contract costs was ~~$1.9~~$0.1 million and ~~$2.5~~$1.9 million, respectively.

The decrease in contract costs, noncurrent portion was ~~primarily~~ attributable to the ~~the~~ reclassification of ~~a portion of~~ costs ~~to fulfill the K-MAX® program and~~on certain structures programs to contract costs, current portion.

Contract Liabilities

The decrease in contract liabilities, current portion was primarily due to revenue recognized on ~~a JPF direct commercial sales ("DCS") contract, K-MAX® spares~~our seals, springs and ~~support and the SH-2G program for New Zealand,~~contacts, partially offset by advances received for ~~K-MAX® spares and support and~~ the SH-2G program for New Zealand. Revenue recognized related to contract liabilities, current portion was ~~$9.4~~$0.5 million and ~~$14.7~~$9.4 million in the three-month fiscal periods ended April ~~2, 2021~~1, 2022 and April ~~3, 2020,~~2, 2021, respectively.

~~The increase in contract liabilities, noncurrent portion was due to advances received for a JPF DCS contract.~~

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April ~~2, 2021~~1, 2022 and April ~~3, 2020,~~2, 2021

(Unaudited)

8. CONTRACT ASSETS, CONTRACT COSTS AND CONTRACT LIABILITIES (CONTINUED)

Contract Liabilities - continued

Contract liabilities, noncurrent portion at April 1, 2022 remained flat compared to the balance at December 31, 2021. For the three-month fiscal periods ended April 1, 2022 and April 2, 2021, the Company did not recognize revenue against contract liabilities, noncurrent portion.

9. FAIR VALUE MEASUREMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date.

The Company uses a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

•Level 1 — Quoted prices in active markets for identical assets or liabilities.

•Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data.

•Level 3 — Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following table presents the carrying value and fair value of financial instruments that are not carried at fair value:


		April 2, 2021				December 31, 2020					April 1, 2022				December 31, 2021
		Carrying Value		Fair Value		Carrying Value		Fair Value			Carrying Value		Fair Value		Carrying Value		Fair Value
In thousands	In thousands									In thousands
Debt (1)	Debt (1)	$	189,657	$	216,525	$	188,919	$	230,093	Debt (1)	$	199,500	$	203,470	$	191,876	$	213,222

(1) These amounts are classified within Level 2.

The above fair values were computed based on quoted market prices and discounted future cash flows (observable inputs), as applicable. Differences from carrying values are attributable to interest rate changes subsequent to when the transactions occurred.

The fair values of cash and cash equivalents, accounts receivable, net and accounts payable - trade approximate their carrying amounts due to the short-term maturities of these instruments. The Company's cash and cash equivalents at April ~~2, 2021~~1, 2022 and December 31, ~~2020~~2021 included ~~$93.5 million and $51.5~~$65.5 million of Level 1 money market funds ~~respectively.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~For the three-month fiscal periods ended April 2, 2021 and April 3, 2020~~

~~(Unaudited)~~

~~9. FAIR VALUE MEASUREMENTS (CONTINUED)~~in both periods.

Recurring Fair Value Measurements

The Company holds derivative instruments for foreign exchange contracts that are measured at fair value using observable market inputs such as forward rates and its counterparties’ credit risks. Based on these inputs, the derivative instruments are classified within Level 2 of the valuation hierarchy. At April ~~2, 2021~~1, 2022 and December 31, ~~2020,~~2021, the derivative instruments were included in other current assets and other current liabilities on the Company's Condensed Consolidated Balance Sheets. Based on the Company's continued ability to trade and enter into forward contracts and interest rate swaps, the Company considers the markets for its fair value instruments to be active.

The Company evaluated the credit risk associated with the counterparties to these derivative instruments and determined that as of April ~~2, 2021,~~1, 2022, such credit risks had not had an adverse impact on the fair value of these instruments.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April 1, 2022 and April 2, 2021

(Unaudited)

10. DERIVATIVE FINANCIAL INSTRUMENTS

The Company is exposed to certain risks relating to its ongoing business operations, including market risks relating to fluctuations in foreign currency exchange rates and interest rates. Derivative financial instruments are recognized on the Condensed Consolidated Balance Sheets as either assets or liabilities and are measured at fair value. Changes in the fair values of derivatives are recorded each period in earnings or accumulated other comprehensive income, depending on whether a derivative is effective as part of a hedged transaction. Gains and losses on derivative instruments reported in accumulated other comprehensive income (loss) are subsequently included in earnings in the periods in which earnings are affected by the hedged item. The Company does not use derivative instruments for speculative purposes.

Forward Exchange Contracts

The Company holds forward exchange contracts designed to hedge forecasted transactions denominated in foreign currencies and to minimize the impact of foreign currency fluctuations on the Company’s earnings and cash flows. Some of these contracts are designated as cash flow hedges. The Company will include in earnings amounts currently included in accumulated other comprehensive income (loss) upon recognition of cost of sales related to the underlying transaction. These contracts were not material to the Company's Condensed Consolidated Balance Sheets as of April ~~2, 2021~~1, 2022 and December 31, ~~2020.~~2021. The activity related to these contracts was not material to the Company's Condensed Consolidated Financial Statements for the three-month fiscal periods ended April ~~2, 2021~~1, 2022 and April ~~3, 2020.~~2, 2021.

11. INVENTORIES

Inventories consisted of the following:


		April 2, 2021		December 31, 2020			April 1, 2022		December 31, 2021
In thousands	In thousands					In thousands
Raw materials	Raw materials	$	19,363	$	19,502	Raw materials	$	21,119	$	19,123
Contracts and other work in process (including certain general stock materials)	Contracts and other work in process (including certain general stock materials)	141,866		129,241		Contracts and other work in process (including certain general stock materials)	151,927		138,737
Finished goods	Finished goods	36,074		36,329		Finished goods	36,481		35,240
Inventories	Inventories	$	197,303	$	185,072	Inventories	$	209,527	$	193,100

Inventories include amounts associated with matters such as contract changes, negotiated settlements and claims for unanticipated contract costs. These amounts were as follows:

April 2,
2021 December 31,
2020
In thousands
Contract changes, negotiated settlements and claims for unanticipated contract costs $ 500 $ 500

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~For the three-month fiscal periods ended April 2, 2021 and April 3, 2020~~

~~(Unaudited)~~

~~11. INVENTORIES (CONTINUED)~~


	April 1, 2022		December 31, 2021
In thousands
Contract changes, negotiated settlements and claims for unanticipated contract costs	$	622	$	552

At April ~~2, 2021~~1, 2022 and December 31, ~~2020, $61.4~~2021, $73.5 million and ~~$60.4~~$69.2 million, respectively, of K-MAX® inventory was included in contracts and other work in process inventory and finished goods on the Company's Condensed Consolidated Balance Sheets. Management believes that approximately ~~$24.5~~$41.2 million of the K-MAX® inventory will be sold after April ~~2, 2022,~~1, 2023, based upon the anticipation of additional aircraft manufacturing and the requirements to support the fleet for the foreseeable future.

At April ~~2, 2021~~1, 2022 and December 31, ~~2020, $6.1~~2021, $5.7 million and ~~$6.3~~$6.0 million, respectively, of SH-2G(I) inventory was included in contracts and other work in process inventory on the Company's Condensed Consolidated Balance Sheets. Management believes that approximately ~~$5.1~~$4.1 million of the SH-2G(I) inventory will be sold after April ~~2, 2022.~~1, 2023. This balance represents spares requirements and inventory to be used on SH-2G programs.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April 1, 2022 and April 2, 2021

(Unaudited)

12. GOODWILL AND OTHER INTANGIBLE ASSETS, NET

Goodwill

The following table sets forth the change in the carrying amount of goodwill for ~~continuing operations:~~each reportable segment and for the Company:


~~In thousands~~
~~Gross balance at December 31, 2020~~	$	~~313,803~~
~~Accumulated impairment~~	~~(66,559)~~
~~Net balance at December 31, 2020~~	~~247,244~~
~~Additions~~	0
~~Impairments~~	0
~~Foreign currency translation~~	~~(3,556)~~
~~Ending balance at April 2, 2021~~	$	~~243,688~~


	Engineered Products		Precision Products		Structures		Total
In thousands
Gross balance at December 31, 2021	$	199,306	$	41,375	$	66,559	$	307,240
Accumulated impairment	—		—		(66,559)		(66,559)
Net balance at December 31, 2021	199,306		41,375		—		240,681
Additions	—		—		—		—
Impairments	—		—		—		—
Foreign currency translation	(2,607)		—		—		(2,607)
Ending balance at April 1, 2022	$	196,699	$	41,375	$	—	$	238,074

Accumulated impairment at end of period	$	—	$	—	$	(66,559)	$	(66,559)

Other ~~Intangibles~~Intangible Assets

Other intangible assets consisted of:


			At April 2,				At December 31,						At April 1,				At December 31,
			2021				2020						2022				2021
		Amortization Period	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization			Amortization Period	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization
In thousands	In thousands										In thousands
Customer lists / relationships	Customer lists / relationships	6-38 years	$	127,974	$	(31,205)	$	128,882	$	(30,094)	Customer lists / relationships	6-38 years	$	126,540	$	(36,095)	$	127,206	$	(35,096)
Developed technologies	Developed technologies	7-20 years	45,458		(10,581)		45,798		(9,665)		Developed technologies	7-20 years	44,922		(14,513)		45,170		(13,591)
Trademarks / trade names	Trademarks / trade names	15-40 years	17,152		(2,242)		17,353		(2,149)		Trademarks / trade names	15-40 years	16,834		(2,756)		16,982		(2,659)
Non-compete agreements and other	Non-compete agreements and other	1-15 years	4,681		(4,668)		5,290		(5,276)		Non-compete agreements and other	1-15 years	4,583		(4,572)		4,629		(4,617)
Patents	Patents	17 years	523		(466)		523		(464)		Patents	17 years	523		(476)		523		(473)
Total	Total		$	195,788	$	(49,162)	$	197,846	$	(47,648)	Total		$	193,402	$	(58,412)	$	194,510	$	(56,436)

13. DEBT

Convertible Notes

During May 2017, the Company issued $200.0 million aggregate principal amount of convertible senior unsecured notes due May 2024 (the "2024 Notes") pursuant to an indenture (the "Indenture"), dated May 12, 2017, between the Company and U.S. Bank National Association, as trustee. In connection therewith, the Company entered into certain capped call transactions that cover, collectively, the number of shares of the Company's common stock underlying the 2024 Notes.

On May 12, 2017, the Company issued $175.0 million in principal amount of 2024 Notes, in a private placement offering. On May 24, 2017, the Company issued an additional $25.0 million in principal amount of 2024 Notes pursuant to the initial purchasers' exercise of their overallotment option, resulting in the issuance of an aggregate $200.0 million principal amount of 2024 Notes. The 2024 Notes bear 3.25% interest per annum on the principal amount, payable semiannually in arrears on May 1 and November 1 of each year, beginning on November 1, 2017. The 2024 Notes will mature on May 1, 2024, unless earlier repurchased by the Company or converted. The Company will settle any conversions of the 2024 Notes in cash, shares of the Company's common stock or a combination of cash and shares of common stock, at the Company's election.

1517

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April ~~2, 2021~~1, 2022 and April ~~3, 2020~~2, 2021

(Unaudited)

13. DEBT (CONTINUED)

Convertible Notes - continued

The sale of the Distribution business in the third quarter of 2019 was deemed to be a "Fundamental Change" and a "Make-Whole Fundamental Change" pursuant to the terms and conditions of the indenture governing the 2024 Notes. As a result, the sale triggered the right of the holders of our 2024 Notes to require us to repurchase all of the 2024 Notes, or any portion thereof that is a multiple of $1,000 principal amount on September 27, 2019. The aggregate principal amount of the 2024 Notes validly tendered and not validly withdrawn was $0.5 million, representing 0.25% of all outstanding notes. Holders of such notes receive the purchase price equal to 100% of the principal amount of the 2024 Notes being purchased, plus accrued and unpaid interest.

The following table illustrates the conversion rate at the date of issuance of the 2024 Notes:


2024 Notes
Conversion Rate per $1,000 principal amount (1)						15.3227
Conversion Price (2)						65.2626
Contingent Conversion Price (3)						84.8413
Aggregate shares to be issued upon conversion (4)						3,056,879

(1)Represents the number of shares of Common Stock hypothetically issuable per each $1,000 principal amount of 2024 Notes, subject to adjustments upon the occurrence of certain specified events in accordance with the terms of the Indenture.

(2)Represents $1,000 divided by the conversion rate as of such date. The conversion price reflects the strike price of the embedded option within the 2024 Notes. If the Company's share price exceeds the conversion price at conversion, the noteholders would be entitled to receive additional consideration either in cash, shares or a combination thereof, the form of which is at the sole discretion of the Company.

(3)Prior to November 1, 2023, the notes are convertible only in the following circumstances: (1) during any fiscal quarter commencing after July 1, 2017, and only during any such fiscal quarter, if the last reported sale price of the Company's common stock was greater than or equal to 130% of the applicable conversion price for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter, (2) during the five consecutive business day period following any ten consecutive trading day period (the "measurement period") in which the trading price per $1,000 principal amount of 2024 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's common stock and the conversion rate on each such trading day or (3) upon the occurrence of specified corporate events. On or after November 1, 2023, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their notes at any time, regardless of the foregoing circumstances. If the Company undergoes a fundamental change (as defined in the Indenture), holders of the notes may require the Company to repurchase all or a portion of their notes for cash at a repurchase price equal to 100% of the principal amount to be repurchased, plus any accrued and unpaid interest. As of April 1, 2022, none of the conditions permitting the holders of the 2024 Notes to convert had been met. Therefore, the 2024 Notes are classified as long-term debt.

(4)This represents the number of shares hypothetically issuable upon conversion of 100% of the outstanding aggregate principal amount of the 2024 Notes at each date; however, the terms of the 2024 Notes state that the Company may pay or deliver, as the case may be, cash, shares of the Company's common stock or a combination of cash and shares of common stock, at the Company's election. The Company currently intends to settle the aggregate principal amount in cash. Amounts due in excess of the principal, if any, also may be settled in cash, shares of the Company's common stock or a combination of cash and shares of common stock, at the Company's election.

In connection with the 2024 Notes offering, the Company entered into capped call transactions with certain of the initial purchasers or their respective affiliates. These transactions are intended to reduce the potential dilution to the Company's shareholders and/or offset the cash payments the Company is required to make in excess of the principal amount upon any future conversion of the notes in the event that the market price per share of the Company's common stock is greater than the strike price of the capped call transactions, with such reduction and/or offset subject to a cap based on the cap price of the capped call transactions. Under the terms of the capped call transactions, the strike price ($65.2626) and the cap price ($88.7570) are each subject to adjustment in certain circumstances. In connection with establishing their initial hedges of the capped call transactions, the option counterparties or their respective affiliates entered into various derivative transactions with respect to the Company’s common stock concurrently with or shortly after the pricing of the notes. The capped call transactions, which cost an aggregate $20.5 million, were recorded as a reduction of additional paid-in capital.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April 1, 2022 and April 2, 2021

(Unaudited)

13. DEBT (CONTINUED)

Convertible Notes - continued

ASC Topic 815 - Derivatives and Hedging ("ASC 815") provides that contracts are initially classified as equity if (1) the contract requires physical settlement or net-share settlement, or (2) the contract gives the company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The settlement terms of our capped call transactions require net-share settlement. Based on the guidance in ASC 815, the capped call transactions were recorded as a reduction of equity as of the trade date. ASC 815 states that a reporting entity shall not consider contracts to be derivative instruments if the contract issued or held by the reporting entity is both indexed to its own stock and classified in shareholders' equity in its balance sheet. The Company concluded the capped call transactions should be accounted for in shareholders' equity and are, therefore, not to be considered a derivative instrument.

At issuance, ASC 470-20 "Debt with Conversion and Other Options" (“ASC 470-20”) clarified the accounting for convertible debt instruments that may be settled in cash upon conversion, including partial cash settlement. ASC 470-20 specified that an issuer of such instruments should separately account for the liability and equity components of the instruments in a manner that reflects the issuer's non-convertible debt borrowing rate which interest costs are to be recognized in subsequent periods. The note payable principal balance for the 2024 Notes at the date of issuance of $200.0 million was bifurcated into the debt component of $179.5 million and the equity component of $20.5 million. The difference between the note payable principal balance and the fair value of the debt component representing the debt discount was being accreted to interest expense over the term of the 2024 Notes. The fair value of the debt component was recognized using a 5.0% discount rate, representing the Company's borrowing rate at the date of issuance for a similar debt instrument without a conversion feature with an expected life of seven years. At January 1, 2022, the Company adopted ASU 2020-06, which removed certain separation models between a debt component and equity component for certain convertible instruments. As a result, the convertible notes balance consists solely of a debt component as of the adoption. Refer to Note 2, Recent Accounting Standards, for further information on the cumulative effect adjustment recorded at adoption.

The Company incurred $7.4 million of debt issuance costs in connection with the sale of the 2024 Notes, which was allocated between the debt and equity components of the instrument at issuance. Of the total amount, $0.7 million was recorded as an offset to additional paid-in capital. The balance, $6.7 million, was recorded as a contra-debt balance and was being amortized over the term of the 2024 Notes. As a result of the adoption of ASU 2020-06, the amount recorded to additional paid-in capital was reclassified to retained earnings in the cumulative effect adjustment. The remaining balance of debt issuance costs is being amortized over the term of the convertible notes. Total amortization expense for the three-month fiscal periods ended April 1, 2022 and April 2, 2021 was $0.2 million in both periods.

The carrying amount of the equity component and the principal amount of the liability component, the unamortized discount and the net carrying value of the liability are as follows:


	2024 Notes
	April 1, 2022		December 31, 2021
In thousands
Principal amount of liability	$	199,500	$	199,500
Unamortized discount(1)	—		7,624
Carrying value of liability	$	199,500	$	191,876

Equity component(1)	$	—	$	20,408

(1)At January 1, 2022, the Company adopted ASU 2020-06, which removed certain separation models between a debt component and equity component for certain convertible instruments. Refer to Note 2, Recent Accounting Standards, for further information on the cumulative effect adjustment recorded at adoption.

Because the embedded conversion option is indexed to the Company’s own stock and would be classified in shareholders’ equity, it does not meet the criterion under ASC 815 that would require separate accounting as a derivative instrument.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April 1, 2022 and April 2, 2021

(Unaudited)

13. DEBT (CONTINUED)

Convertible Notes - continued

Interest expense associated with the 2024 Notes consisted of the following:


	For the Three Months Ended
	April 1, 2022		April 2, 2021
In thousands
Contractual coupon rate of interest	$	1,621	$	1,621
Accretion of convertible notes discount(1)	—		737
Interest expense - convertible notes	$	1,621	$	2,358

(1)In accordance with ASU 2020-06, entities that previously required separate accounting for conversion features will report less interest expense as those conversion features were recorded as debt discounts which were amortized over the term of the debt. Refer to Note 2, Recent Accounting Standards, for further information on the adoption of ASU 2020-06.

The weighted average interest rate on long-term borrowings outstanding as of April 1, 2022 and December 31, 2021 was 3.25% in both periods.

14. PENSION PLANS

Components of net pension cost for the Qualified Pension Plan and Supplemental Employees’ Retirement Plan ("SERP") were as follows:


		For the Three Months Ended									For the Three Months Ended
		Qualified Pension Plan				SERP					Qualified Pension Plan				SERP
		April 2, 2021		April 3, 2020		April 2, 2021		April 3, 2020			April 1, 2022		April 2, 2021		April 1, 2022		April 2, 2021
In thousands	In thousands									In thousands
Service cost	Service cost	$	1,300	$	1,309	$	0	$	0	Service cost	$	800	$	1,300	$	—	$	—
Interest cost on projected benefit obligation	Interest cost on projected benefit obligation	3,525		5,255		15		41		Interest cost on projected benefit obligation	4,250		3,525		22		15
Expected return on plan assets	Expected return on plan assets	(11,275)		(10,796)		0		0		Expected return on plan assets	(10,525)		(11,275)		—		—
Amortization of net loss	Amortization of net loss	1,075		1,201		17		236		Amortization of net loss	975		1,075		15		17
Net pension (income) cost	Net pension (income) cost	$	(5,375)	$	(3,031)	$	32	$	277	Net pension (income) cost	$	(4,500)	$	(5,375)	$	37	$	32

~~The Company contributed $10.0 million~~No contributions are expected to be made to the qualified pension plan ~~subsequent to the end of the first quarter, and~~during 2022. The Company contributed $0.1 million to the SERP through the end of the first quarter of ~~2021. NaN further contributions are expected to be made to the qualified pension plan during 2021. The Company~~2022 and plans to contribute an additional ~~$2.6~~$0.4 million to the SERP in ~~2021.~~2022. For the ~~2020~~2021 plan year, the Company contributed $10.0 million to the qualified pension plan and ~~$0.5~~$2.7 million to the SERP.

~~14.~~15. COMMITMENTS AND CONTINGENCIES

Pension Freeze

Effective December 31, 2015, the Company's qualified pension plan was frozen with respect to future benefit accruals. Under USG Cost Accounting Standard (“CAS”) 413, the Company must determine the USG’s share of any pension curtailment adjustment calculated in accordance with CAS. Such adjustments can result in an amount due to the USG for pension plans that are in a surplus position or an amount due to the contractor for plans that are in a deficit position. During the fourth quarter of 2016, the Company accrued a $0.3 million liability representing its estimate of the amount due to the USG based on the Company's pension curtailment adjustment calculation, which was submitted to the USG for review in December 2016. The Company maintained its accrual at $0.3 million as of April ~~2, 2021.~~1, 2022. There can be no assurance that the ultimate resolution of this matter will not have a material adverse effect on the Company's results of operations, financial position and cash flows.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April 1, 2022 and April 2, 2021

(Unaudited)

15. COMMITMENTS AND CONTINGENCIES (CONTINUED)

New Hartford Property

In connection with the sale of the Company’s Music segment in 2007, the Company assumed responsibility for meeting certain requirements of the Connecticut Transfer Act (the “Transfer Act”) that applied to the transfer of the New Hartford, Connecticut, facility leased by that segment for guitar manufacturing purposes (“Ovation”). Under the Transfer Act, those responsibilities essentially consist of assessing the site's environmental conditions and remediating environmental impairments, if any, caused by Ovation's operations prior to the sale. The site is a multi-tenant industrial park, in which Ovation and other unrelated entities lease space. The environmental assessment process, which began in 2008, has been completed and site remediation is in process.

The Company's estimate of its portion of the cost to assess the environmental conditions and remediate this site is $2.3 million, all of which has been accrued. The remediation has been nearly completed and the Company continues to monitor the results of the remediation. The total amount paid to date in connection with these environmental remediation activities is $1.7 million. At April ~~2, 2021,~~1, 2022, the Company had $0.6 million accrued for these environmental remediation activities. A portion ($0.1 million) of the accrual related to this property is included in other current liabilities and the balance is included in other long-term liabilities. The remaining balance of the accrual reflects the total anticipated cost of completing these environmental remediation activities. Although it is reasonably possible that additional costs will be paid in connection with the resolution of this matter, the Company is unable to estimate the amount of such additional costs, if any, at this time.

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~For the three-month fiscal periods ended April 2, 2021 and April 3, 2020~~

~~(Unaudited)~~

~~14. COMMITMENTS AND CONTINGENCIES (CONTINUED)~~

Bloomfield Property

In connection with the Company’s 2008 purchase of the portion of the Bloomfield campus that Kaman Aerospace Corporation had leased from NAVAIR, the Company assumed responsibility for environmental remediation at the facility as may be required under the Transfer Act and is currently remediating the property under the guidance of the Connecticut Department of Environmental Protection. The assumed environmental liability of $10.3 million was determined by taking the undiscounted estimated remediation liability of $20.8 million and discounting it at a rate of 8%. This remediation process will take many years to complete. The total amount paid to date in connection with these environmental remediation activities is ~~$14.5~~$14.9 million. At April ~~2, 2021,~~1, 2022, the Company had ~~$2.4~~$2.3 million accrued for these environmental remediation activities. A portion ($~~0.6~~0.2 million) of the accrual related to this property is included in other current liabilities, and the balance is included in other long-term liabilities. Although it is reasonably possible that additional costs will be paid in connection with the resolution of this matter, the Company is unable to estimate the amount of such additional costs, if any, at this time.

Offset Agreement

During January 2018, the Company entered into an offset agreement as a condition to obtaining orders from a foreign customer for the Company's JPF product. This agreement is designed to return economic value to the foreign country by requiring the Company to engage in activities supporting local defense or commercial industries, promoting a balance of trade, developing in-country technology capabilities or addressing other local development priorities. The offset agreement may be satisfied through activities that do not require a direct cash payment, including transferring technology, providing manufacturing, training and other consulting support to in-country projects and the purchase by third parties of supplies from in-country vendors. This agreement may also be satisfied through the Company's use of cash for activities, such as subcontracting with local partners, purchasing supplies from in-country vendors, providing financial support for in-country projects and making investments in local ventures. At April ~~2, 2021,~~1, 2022, the offset agreement had an outstanding notional value of approximately $194.0 million, which is equal to 60 percent of the contract value of $324.0 million as defined by the agreement between the customer and the Company. The amount ultimately applied against the offset agreement is based on negotiations with the customer and may require cash outlays that represent only a fraction of the notional value in the offset agreement.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April 1, 2022 and April 2, 2021

(Unaudited)

15. COMMITMENTS AND CONTINGENCIES (CONTINUED)

Offset Agreement - continued

The Company continues to work with the customer to further define the requirements to satisfy the offset agreement. The satisfaction of the offset requirements will be determined by the customer and is expected to occur over a seven-year period. Deliveries under the contract ~~are expected to be~~were completed prior to satisfaction of the offset requirements. In the event the offset requirements of the contract are not met, the Company could be liable for potential penalties up to $16.5 million payable to the customer. Failure to satisfy the offset requirement could also negatively impact the Company's ability to attract future orders from this customer. The Company began recognizing revenue associated with this contract in the third quarter of 2019 and has considered the potential penalties of $16.5 million as a reduction to the transaction price in its determination of the value of the performance obligations within this contract. At April ~~2, 2021, $12.1~~1, 2022, $16.5 million in contract liabilities associated with the potential penalties of the offset requirements were included on the Company's Condensed Consolidated Balance Sheets. At the point the Company has an approved plan to satisfy the offset requirements, the Company will update the estimate of the contract transition price, including any potential penalties or contract costs associated with the plan to fulfill the offset requirements.

Guarantee

During 2020, the Company and the USG entered into a Guaranty Agreement, pursuant to which the Company agreed to guarantee the full, complete and satisfactory performance of its subsidiary, Kaman Precision Products, Inc. ("KPPI") under all current and future contracts with the USG. As of the date of this filing, the only contract in place between KPPI and the USG relates to the production and sale of the JPF. KPPI is currently fulfilling the requirements of Option 15 and ~~has completed pricing negotiations on~~ Option 16. The guarantee was provided in lieu of a periodic financial capability review by the Financial Capacity Team ("FCT") of the Defense Contract Management Agency ("DCMA"). The Company is unable to estimate the maximum potential amount of future payments under the guarantee as it is dependent on costs incurred by the USG in the event of default. Although the Company believes the risk of default is low given the maturity and operational performance of the JPF program, there can be no assurance that the guarantee will not have a material adverse effect on the Company's results of operations, financial position and cash flows.

1722

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April ~~2, 2021~~1, 2022 and April ~~3, 2020~~2, 2021

(Unaudited)

~~15.~~16. COMPUTATION OF EARNINGS PER SHARE

The computation of basic earnings per share is based on net earnings divided by the weighted average number of shares of common stock outstanding for each period. The computation of diluted earnings per share reflects the common stock equivalency of dilutive options granted to employees under the Company's stock incentive plan, shares issuable on redemption of its convertible notes and shares issuable upon redemption of outstanding warrants.


	For the Three Months Ended
	April 1, 2022		April 2, 2021
In thousands, except per share amounts
Net earnings	$	4,028	$	7,984

Basic:
Weighted average number of shares outstanding	27,950		27,815
Basic earnings per share	$	0.14	$	0.29

Diluted(1):
Weighted average number of shares outstanding	27,950		27,815
Weighted average shares issuable on exercise of dilutive stock options	132		52
Total	28,082		27,867

Diluted earnings per share	$	0.14	$	0.29

For the Three Months Ended
April 2,
2021 April 3,
2020
In thousands, except per share amounts
Earnings (loss) from continuing operations $ 7,984 $ (407)
Total earnings from discontinued operations 0 692
Net earnings (loss) $ 7,984 $ 285
Basic:
Weighted average number of shares outstanding 27,815 27,809
Earnings (loss) per share from continuing operations $ 0.29 $ (0.01)
Earnings per share from discontinued operations 0.00 0.02
Basic earnings (loss) per share $ 0.29 $ 0.01
Diluted:
Weighted average number of shares outstanding 27,815 27,809
Weighted average shares issuable on exercise of dilutive stock options 52 82
Total 27,867 27,891
Earnings (loss) per share from continuing operations $ 0.29 $ (0.01)
Earnings per share from discontinued operations 0.00 0.02
Diluted earnings (loss) per share $ 0.29 $ 0.01
(1)As a result of the adoption of ASU 2020-06, the Company began calculating diluted earnings per share using the if-converted method for its convertible debt instruments in 2022. Prior to the adoption, the Company calculated diluted earnings per share for its convertible debt instruments using the treasury stock method. The Company adopted ASU 2020-06 using the modified retrospective approach; therefore, prior period results have not been retroactively adjusted. Refer to Note 2, Recent Accounting Standards, for further information on the adoption of ASU 2020-06.

Equity awards

For the three-month fiscal periods ended April 1, 2022 and April 2, 2021, respectively, 645,403 and ~~April 3, 2020, respectively,~~ 440,959 ~~and 443,379~~ shares issuable under equity awards granted to employees were excluded from the calculation of diluted earnings per share as they were anti-dilutive based on the average stock price during the periods.

2024 Convertible Notes

For the three-month fiscal ~~periods~~period ended April 1, 2022, 3,056,879 shares issuable under Convertible Notes due 2024 were excluded from the diluted earnings per share calculation because their effect was antidilutive. For the three-month fiscal period ended April 2, 2021, ~~and April 3, 2020,~~ shares issuable under the Convertible Notes due 2024 were excluded from the diluted earnings per share calculation because the conversion price was more than the average market price of the Company's stock during the periods.

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~For the three-month fiscal periods ended April 2, 2021 and April 3, 2020~~

~~(Unaudited)~~

~~16.~~17. SHARE-BASED ARRANGEMENTS

The Company accounts for stock options, restricted stock awards ("RSAs"), restricted stock units and performance stock units ("PSUs") as equity awards and measures the cost of all share-based payments, including stock options, at fair value on the grant date and recognizes this cost in the statement of operations. The Company also has an employee stock purchase plan, which is accounted for as a liability award.

In 2021, the Company modified its long-term incentive program to increase the emphasis on equity. Beginning in the first quarter of 2021, the long-term incentive awards granted to the Company's Named Executive Officers ("NEOs") will consist of a combination of service-based RSAs and PSUs which are intended to be settled in shares, as opposed to cash-based awards that had been utilized in the past. These awards are expected to increase the alignment of interests between the Company's NEOs and shareholders and help build stock ownership for new executives, supporting both executive retention and the Company's long-term financial performance. RSAs will vest over a three-year period on each of the first three anniversaries of the date of grant. The number of PSUs that will vest will be determined based on total shareholder return ("TSR") and return on total invested capital ("ROIC") over a three-year performance period, each of which will remain equally weighted in determining payouts. The achievement level for both factors may range from 0 to 200%.

Compensation expense for stock options, RSAs, restricted stock units and PSUs is recognized on a straight-line basis over the vesting period of the awards. Throughout the course of the vesting period, the Company monitors the achievement level for the ROIC metric of the PSUs compared to the ROIC target and adjusts the number of shares expected to be earned, and the related compensation expense recorded thereafter, to reflect the most probable outcome. Share-based compensation expense recorded for the three-month fiscal periods ended April 1, 2022 and April 2, 2021 ~~and April 3, 2020~~ was ~~$1.7~~$2.1 million and ~~$1.6~~$1.7 million, respectively. These amounts were ~~included in~~recorded to selling, general and administrative expenses on the Company's Condensed Consolidated Statements of Operations.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April 1, 2022 and April 2, 2021

(Unaudited)

17. SHARE-BASED ARRANGEMENTS (CONTINUED)

Stock option activity was as follows:

For the Three Months Ended
April 2, 2021
Options Weighted - average
exercise price
Options outstanding at beginning of period 772,625 $ 54.87
Granted 4,990 $ 55.85
Exercised (11,095) $ 38.74
Forfeited or expired 0 $ 0
Options outstanding at April 2, 2021 766,520 $ 55.11


	For the Three Months Ended
	April 1, 2022
	Options	Weighted - average exercise price
Options outstanding at beginning of period	746,240	$	55.14
Granted	—	$	—
Exercised	(9,676)	$	41.63
Forfeited or expired	(3,071)	$	61.76
Options outstanding at April 1, 2022	733,493	$	55.29

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model. No options were granted in the three-month fiscal period ended April 1, 2022. The following table indicates the weighted-average assumptions used in estimating fair ~~value:~~value for the three-month fiscal period ended April 2, 2021:

For the Three Months Ended
April 2,
2021 April 3,
2020
Expected option term (years) 4.9 4.9
Expected volatility 35.7 % 20.2 %
Risk-free interest rate 0.5 % 1.4 %
Expected dividend yield 1.6 % 1.3 %
Per share fair value of options granted $14.89 $10.74


	For the Three Months Ended
	April 2, 2021
Expected option term (years)	4.9
Expected volatility	35.7	%
Risk-free interest rate	0.5	%
Expected dividend yield	1.6	%
Per share fair value of options granted	$14.89

Restricted stock award and restricted stock unit activity were as follows:


	For the Three Months Ended
	April 1, 2022
	Restricted Stock	Weighted- average grant date fair value
Restricted Stock outstanding at beginning of period	135,351	$	53.53
Granted	80,115	$	41.64
Vested	(46,598)	$	52.85
Forfeited or expired	(4,077)	$	52.90
Restricted Stock outstanding at April 1, 2022	164,791	$	47.96

Performance stock unit activity was as follows:


	For the Three Months Ended
	April 1, 2022
	Performance Stock	Weighted- average grant date fair value
Performance Stock outstanding at beginning of period	70,163	$	70.17
Granted(1)	117,885	$	54.87
Vested	—	$	—
Forfeited or expired	(3,643)	$	61.07
Performance Stock outstanding at April 1, 2022	184,405	$	60.98

(1) The PSUs granted in 2022 and 2021 assumed a 100% achievement level.

1924

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April ~~2, 2021~~1, 2022 and April ~~3, 2020~~2, 2021

(Unaudited)

~~16.~~17. SHARE-BASED ARRANGEMENTS (CONTINUED)

~~Restricted stock award and restricted stock unit activity were as follows:~~

For the Three Months Ended
April 2, 2021
Restricted Stock Weighted-
average grant
date fair value
Restricted Stock outstanding at beginning of period 109,514 $ 53.66
Granted 66,975 $ 55.88
Vested (26,151) $ 57.56
Forfeited or expired 0 $ 0
Restricted Stock outstanding at April 2, 2021 150,338 $ 53.97

~~Performance stock unit activity was as follows:~~

For the Three Months Ended
April 2, 2021
Performance Stock Weighted-
average grant
date fair value
Performance Stock outstanding at beginning of period 0 $ 0
Granted(1)
82,460 $ 70.17
Vested 0 $ 0
Forfeited or expired 0 $ 0
Performance Stock outstanding at April 2, 2021 82,460 $ 70.17

~~(1)~~ ~~The PSUs granted in the first quarter of 2021 assumed a 100% achievement level.~~

The fair value of the PSUs based on TSR was estimated on the date of grant using a Monte-Carlo simulation model. The following table indicates the weighted-average assumptions used in estimating fair value:


		For the Three Months Ended				For the Three Months Ended
		April 2, 2021				April 1, 2022			April 2, 2021
Expected term (years)	Expected term (years)	2.9			Expected term (years)	2.9			2.9
Expected volatility	Expected volatility	41.3		%	Expected volatility	39.4		%	41.3		%
Risk-free interest rate	Risk-free interest rate	0.2		%	Risk-free interest rate	1.7		%	0.2		%
Expected dividend yield	Expected dividend yield	1.4		%	Expected dividend yield	1.9		%	1.4		%
Per share fair value of performance stock granted	Per share fair value of performance stock granted	$	84.49		Per share fair value of performance stock granted	$	68.10		$	84.49

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~For the three-month fiscal periods ended April 2, 2021 and April 3, 2020~~

~~(Unaudited)~~

~~17.~~18. SHAREHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME

Changes in shareholders’ equity for the three-month fiscal periods ended April ~~2, 2021,~~1, 2022, and April ~~3, 2020,~~2, 2021, were as follows:


		For the Three Months Ended					For the Three Months Ended
		April 2, 2021		April 3, 2020			April 1, 2022		April 2, 2021
In thousands	In thousands					In thousands
Beginning balance	Beginning balance	$	746,438	$	823,202	Beginning balance	$	796,329	$	746,438
Comprehensive income (loss)		24,339		(9,434)
Comprehensive (loss) income						Comprehensive (loss) income	(428)		24,339
Dividends declared (per share of common stock, $0.20 and $0.20, respectively)	Dividends declared (per share of common stock, $0.20 and $0.20, respectively)	(5,562)		(5,555)		Dividends declared (per share of common stock, $0.20 and $0.20, respectively)	(5,590)		(5,562)
Employee stock plans and related tax benefit	Employee stock plans and related tax benefit	880		1,455		Employee stock plans and related tax benefit	785		880
Purchase of treasury shares	Purchase of treasury shares	(344)		(14,072)		Purchase of treasury shares	(575)		(344)
Share-based compensation expense	Share-based compensation expense	1,743		1,633		Share-based compensation expense	2,081		1,743
Impact of change in tax accounting standard		(275)		0
Impact of change in accounting standard						Impact of change in accounting standard	(5,854)		(275)
Ending balance	Ending balance	$	767,219	$	797,229	Ending balance	$	786,748	$	767,219

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended April 1, 2022 and April 2, 2021

(Unaudited)

18. SHAREHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME (CONTINUED)

The components of accumulated other comprehensive income (loss) are shown below:


		For the Three Months Ended					For the Three Months Ended
		April 2, 2021		April 3, 2020			April 1, 2022		April 2, 2021
In thousands	In thousands					In thousands
Foreign currency translation and other:	Foreign currency translation and other:					Foreign currency translation and other:
Beginning balance	Beginning balance	$	(717)	$	(16,351)	Beginning balance	$	8,772	$	(717)
Net loss on foreign currency translation	Net loss on foreign currency translation	(7,322)		(10,826)		Net loss on foreign currency translation	(5,218)		(7,322)
Reclassification to net income(1)	Reclassification to net income(1)	22,835		0		Reclassification to net income(1)	—		22,835
Other comprehensive income (loss), net of tax	Other comprehensive income (loss), net of tax	15,513		(10,826)		Other comprehensive income (loss), net of tax	(5,218)		15,513
Ending balance	Ending balance	$	14,796	$	(27,177)	Ending balance	$	3,554	$	14,796

Pension and other post-retirement benefits(2):	Pension and other post-retirement benefits(2):					Pension and other post-retirement benefits(2):
Beginning balance	Beginning balance	$	(130,104)	$	(134,542)	Beginning balance	$	(120,157)	$	(130,104)
Amortization of net loss, net of tax expense of $250 and $330, respectively		842		1,107
Amortization of net loss, net of tax expense of $228 and $250, respectively						Amortization of net loss, net of tax expense of $228 and $250, respectively	762		842
Other comprehensive income, net of tax	Other comprehensive income, net of tax	842		1,107		Other comprehensive income, net of tax	762		842
Ending balance	Ending balance	$	(129,262)	$	(133,435)	Ending balance	$	(119,395)	$	(129,262)

Total accumulated other comprehensive loss	Total accumulated other comprehensive loss	$	(114,466)	$	(160,612)	Total accumulated other comprehensive loss	$	(115,841)	$	(114,466)

(1) The foreign currency translation reclassified to net income relates to the sale of the Company's UK Composites business. This balance was included in the loss accrual recorded in impairment on assets held for sale on the Company's Consolidated Statement of Operations in the year ended December 31, 2020 (see Note 3, Disposals, for additional information).

(2) These accumulated other comprehensive income components are included in the computation of net periodic pension cost.

(See Note ~~13,~~14, Pension Plans for additional information.)

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~For the three-month fiscal periods ended April 2, 2021 and April 3, 2020~~

~~(Unaudited)~~

~~18.~~19. INCOME TAXES

For the Three Months Ended
April 2,
2021 April 3,
2020
Effective Income Tax Rate from continuing operations 2.5 % 52.1 %


	For the Three Months Ended
	April 1, 2022		April 2, 2021

Effective Income Tax Rate	24.5	%	2.5	%

The effective income tax rate represents the combined federal, state and foreign tax effects attributable to pretax earnings ~~from continuing operations~~ for the period. The ~~decrease~~increase in the effective tax rate ~~from continuing operations~~ for the three-month fiscal period ended April ~~2, 2021, compared~~1, 2022 to the corresponding rate in the prior year was primarily caused by a discrete benefit ~~received~~recorded in the ~~current~~prior period related to the sale of the ~~Company's~~Company’s former UK Composites ~~business and the positive earnings in the current period versus a loss in the prior period.~~

A valuation allowance for deferred tax assets, including those associated with net operating loss carryforwards, is recognized when it is more likely than not that some or all of the benefit from the deferred tax asset will not be realized. To assess that likelihood, the Company uses estimates and judgment regarding future taxable income, and considers the tax consequences in the jurisdiction where such taxable income is generated, to determine whether a valuation allowance is required. Such evidence can include current financial position, results of operations, both actual and forecasted, the reversal of deferred tax liabilities, and tax planning strategies, as well as the current and forecasted business economics.

The Company has assessed both positive and negative evidence to estimate whether sufficient future taxable income will be generated to utilize the $35.1 million of deferred tax assets recorded as of April 2, 2021. Through the end of the first quarter of 2021, the Company believes it is more likely than not that only $30.3 million of these deferred tax assets will be realized and, as such, has recorded a valuation allowance of $4.8 million. Going forward, management will continue to assess the available positive and negative evidence to determine whether it is likely sufficient future taxable income will be generated to permit the use of these deferred tax assets. The amount of the deferred tax asset considered realizable could be adjusted if estimates of future taxable income are reduced or increased, or if additional weight is given to subjective evidence such as future expected growth because objective negative evidence in the form of cumulative losses is no longer present.business.

~~19.~~20. SUBSEQUENT EVENTS

The Company has evaluated subsequent events through the issuance date of these financial statements. No material subsequent events were identified that require disclosure.

2226

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations is intended to provide readers of our condensed consolidated financial statements with the perspectives of management. It presents, in narrative and tabular form, information regarding our financial condition, results of operations, liquidity and certain other factors that may affect our future results, and is designed to enable the readers of this report to obtain an understanding of our businesses, strategies, current trends and future prospects. It should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, ~~2020~~2021 ("~~2020~~2021 Form 10-K") and the Condensed Consolidated Financial Statements included in Item 1 of this Form 10-Q.

OVERVIEW OF BUSINESS

Kaman Corporation ~~(the "Company" or "Kaman"~~("the Company") ~~currently~~ conducts business inthrough three business segments:

•The Engineered Products segment serves the aerospace and defense, industrial and medical ~~markets. Kaman produces and~~ markets providing sophisticated, proprietary aircraft bearings and components; super precision, miniature ball ~~bearings,~~bearings; and proprietary spring energized seals, springs and ~~contacts;~~contacts.

•The Precision Products segment serves the aerospace and defense markets providing precision safe and arming solutions for missile and bomb systems for the U.S. and allied militaries; subcontract helicopter work; restoration, modification and support of our SH-2G Super Seasprite maritime helicopters; manufacture and support of our heavy lift K-MAX® manned helicopter, the TITAN UAV aerial system and the KARGO UAV unmanned aerial system, a purpose built autonomous medium lift logistics vehicle.

•The Structures segment serves the aerospace and defense and medical end markets providing sophisticated complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing ~~aircraft;~~aircraft, and safe and arming solutions for missile and bomb systems for the U.S. and allied militaries. The Company also manufactures and supports our K-MAX® manned and unmanned medium-to-heavy lift helicopters and restores, modifies and supports our SH-2G Super Seasprite maritime helicopters.medical imaging solutions.

Executive Summary

In the first quarter, consolidated net sales ~~from continuing operations~~ decreased by ~~17.2%~~7.9% to ~~$171.6~~$158.0 million compared to the prior year, primarily due to ~~a reduction in~~lower sales on our safe and ~~arms device~~arm devices and ~~commercial business and general aviation~~defense programs. Gross margin ~~decreased~~as a percentage of sales increased in the quarter to ~~30.8%~~32.0% compared to ~~32.7%~~30.8% in the prior year ~~period. This~~period, due to improved performance ~~was driven in part by the mix of joint programmable fuze ("JPF") sales in the quarter and lower sales and associated gross profit~~ on our ~~commercial~~seals, springs and contacts and bearings ~~products due to the impacts of COVID-19.~~products. Selling, general and administrative expenses ("S,G&A") ~~decreased~~increased by ~~26.2%, driven by the absence of Bal Seal acquisition costs~~4.2% primarily due to higher travel expenses and ~~lower employee-related costs as we realize the benefits of the workforce reductions implemented in the prior year.~~trade show costs. Operating income in the period ~~benefited from~~decreased as a result of lower sales and gross profit and higher SG&A and research and development costs, partially offset by the absence of ~~costs associated with the acquired retention plans incurred in the prior year and lower~~ costs related to the transition services agreement ("TSA")~~. Bal Seal was able to recover quickly from the interruption to its information technology systems,~~ and as such, there was no material impact to our first quarter results. GAAP diluted earnings per share of $0.29 in the first quarter was the result of the activity discussed above and higher pension-related income, partially offset by lower ~~income from the TSA.~~severance costs.

Other financial highlights

•~~Earnings from continuing operations was $8.0~~Net earnings were $4.0 million for the three-month fiscal period ended April ~~2, 2021, compared to a loss from continuing operations of $0.4~~1, 2022, $4.0 million inlower than the ~~comparable~~ fiscal period in the prior year. This ~~change~~reduction was primarily driven by the ~~absence of Bal Seal acquisition costs~~decrease in operating income discussed above, lower non-service pension and ~~costs associated with the acquired retention plans incurred~~post retirement benefit income and a normalized income tax rate, which resulted in ~~the prior year,~~higher income tax expense. These changes were partially offset by lower ~~sales and gross profit.~~interest expense. The resulting GAAP diluted earnings per share was $0.14 in the first quarter of 2022.

•Cash used in operating activities ~~of continuing operations~~ during the three-month fiscal period ended April ~~2, 2021,~~1, 2022, was ~~$2.4~~$1.0 million, a ~~$53.0~~$1.4 million improvement to the comparable fiscal period in the prior year. This change was ~~primarily due to the collection of payments on outstanding receivables, more specifically significant receivables under a JPF direct commercial sales ("DCS") contract, and~~largely driven by the absence of ~~a $10.0 million pension contribution in the current period, partially offset by~~ approximately $25.1 million in nonrecurring payments to eligible participants of Bal Seal's employee retention ~~plans.~~plans implemented prior to our acquisition, partially offset by the timing of collection of payments on outstanding receivables in the prior year, more specifically significant receipts on joint programmable fuze ("JPF") direct commercial sales ("DCS") receivables.

•Total unfulfilled performance obligations ("backlog") ~~decreased 10.9%~~increased 0.6% to ~~$562.4~~$705.0 million compared to total backlog at December 31, ~~2020,~~2021, driven ~~by deliveries of direct commercial JPF orders and bearings products, partially offset~~ by new orders of our bearings ~~products.~~products and seals, springs and contacts, partially offset by sales on our JPF program with the U.S. Government ("USG") and deliveries of our bearing products and seals, springs and contacts.

Recent events

•In April ~~2021, the K-MAX TITAN~~TM ,2022, our ~~new unmanned helicopter, successfully completed its first test flight.~~

•~~In April 2021, Ian K. Walsh, President and CEO, was appointed Chairman of the~~ Board of Directors ~~and Jennifer Pollino assumed~~approved a share repurchase program authorizing the ~~role~~repurchase of ~~Lead Independent Director.~~

•~~In March 2021, we opened~~up to $50.0 million of our ~~first production cell for highly engineered products utilizing our proprietary Titanium Diffusion Hardening process.~~

•~~In March 2021, we were awarded a contract by Boeing to manufacture the refueling boom assembly for the MH-47 program. The program is expected to start in the second half of 2021.~~common stock.

2327

•In March 2022, we secured $7.0 million in USG funding for our K-MAX® Autonomous Logistics Systems.

•In March 2022, we announced that our Jacksonville division received a follow on award from Sikorsky for the HH-60W Combat Rescue Helicopter ("CRH") cockpit. This award secures deliveries from 2022 through 2025.

•In February ~~2021, we completed~~2022, Kamatics Corporation introduced new P-54 contoured, anti-wear components for the ~~sale~~maintenance, repair, and overhaul ("MRO") of legacy helicopter gearboxes.

•In February 2022, Kineco Kaman Composites India Private Limited, our ~~UK Composites business.~~joint venture with Goa-based Kineco Limited, delivered its 600th Mission Crew Workstation Console to BAE Systems USA, used in the Boeing P-8 Poseidon maritime patrol aircraft.

•In February 2022, our FAA Part 145 Repair Station in Wichita, Kansas earned Federal Aviation Approval ("FAA") approval for two new composite repair capabilities.

•In January ~~2021,~~2022, we ~~received~~announced the expansion of our medical imaging program through a ~~signed purchase agreement for a K-MAX® medium-to-heavy lift helicopter. Delivery~~partnership with Mirion Technologies ("Mirion"). We will supply surgical C-Arm tabletops to Mirion with deliveries expected to begin in the second quarter of ~~this aircraft was completed in March 2021.~~2022.

•In January ~~2021,~~2022, we announced that our Kamatics business will support the Agencia Nacional de Aviação Civil ("ANAC") in Brazil issued the Type Certificate for the Kaman K-1200 K-MAX® helicopter. We have been marketing the K-MAX® helicopter to various Brazilian operators, power line, oil and gas firms, and engineering companies over the past two years, and this certification clears the path for K-MAX® operations in Brazil.new James Webb Telescope with its KAron® high technology, self-lubricating bearings.

~~COVID-19 Discussion~~Impacts from Current Economy

~~The~~We are currently operating in a period of global economic uncertainty, which has been significantly impacted by geopolitical instability due to the ongoing military conflict between Ukraine and Russia. U.S. and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions, including the start of the military conflict in Ukraine and the resulting sanctions imposed on Russia. Although the length and impact of the ~~novel coronavirus (“COVID-19”) and~~ongoing military conflict is highly unpredictable, the ~~precautionary measures instituted by governments and businesses~~conflict in Ukraine could lead to ~~mitigate the spread,~~market disruptions, including limiting non-essential gatherings of people, ceasing all non-essential travel, ordering certain businesses and government agencies to cease non-essential operations at physical locations and issuing “shelter-in-place” orders, have contributed to a general slowdown in the global economy and significant volatility in ~~financial~~credit and capital markets, ~~including a decrease in our stock price.~~commodity prices and supply chain interruptions, as well as the potential for increased cyber disruptions. We are ~~closely monitoring~~continuing to monitor the situation in Ukraine, including its global effects, and assessing its potential impact on our business, including the timing of our sales as certain customers purchase safety stock for their own supply chains. Although our business has not been materially impacted by the ongoing military conflict in Ukraine as of the date of this filing, it is impossible to predict the extent to which our operations, or those of our customers or suppliers, will be impacted, or the ways in which the conflict may impact our business, cash flows or results of operations.

We also continue to monitor the impact of the ~~COVID-19~~coronavirus ("COVID-19") pandemic on all aspects of our business and across the geographies in which we operate and serve customers, ~~and we are working to assess~~as well as the extent to which it has impacted and will continue to impact our customers, suppliers and other business partners.

~~Impact on~~ We are operating below pre-pandemic levels for our ~~Business~~

~~Kaman is operating as an essential business in the United States~~commercial aerospace products and ~~in most of the markets in which it operates around the world. Despite efforts to mitigate the risks associated with COVID-19,~~ we ~~expect our operations to continue to be adversely impacted through at least the first half of 2021. Additionally, certain of our customers and suppliers~~ have ~~temporarily shut down operations; however,~~seen some disruptions to our supply chain, ~~have been limited to date~~such as delays in materials and components used in our manufacturing process; however, we continue to meet the demands of our customers. ~~While~~We are encouraged by the recoveries for these products and the strong order intake we ~~did not incur significant disruptions related to the COVID-19 pandemic during the first quarter of 2021, we continued to see declines in our commercial aerospace products~~saw in the first ~~quarter~~three months of ~~2021~~2022; however, the developments related to COVID-19 variants make it difficult to predict the timing and magnitude of the recovery.

The U.S. economy is experiencing broad and rapid inflation as ~~compared~~well as supply issues in material, service and labor due to ~~the corresponding period in 2020 which was minimally impacted by COVID-19. As~~economic policy, the pandemic ~~continues, we anticipate further challenges~~and, more recently, the war in ~~our commercial aerospace programs~~Ukraine. These impacts are likely to persist through 2022 and beyond. We cannot predict the ~~first half of 2021; however, we expect a meaningful ramp in sales for these products in~~impact on the ~~second half~~Company’s end markets or input costs nor the ability of the ~~year due~~Company to ~~the increase in air traffic and vaccination rates in the United States. We saw recoveries in our medical and industrial end markets during the first quarter and expect improved performance~~recover cost increases through the remainder of 2021. Our defense and safe and arm device end markets have not been impacted by COVID-19 and we do not expect future declines due to COVID-19 on the results of these end markets. The extent to which COVID-19 may adversely impact the Company depends on future developments, which are highly uncertain and unpredictable at this time.

~~Steps to Protect our Workforce~~

The health and safety of our employees, their families and communities, and our customers are our highest priorities. To maintain employee productivity and minimize the risk of exposure while working, we continue to adhere to the policies and procedures implemented in the prior year to allow our employees to work with confidence knowing that their health and safety is a key priority. All employees who are able to work from home have been encouraged to do so for the foreseeable future to limit contact points and reduce the risk of exposure. For those on-site, we continue to operate in segregated workspaces to maintain physical distancing within our facilities, better trace employee contacts, and limit risk of exposure while in the facility. We have also restricted free flow of employees throughout the factories and prevented non-essential employees and business associates from entering these facilities. In addition, we continue to require daily temperature checks and face masks for all persons entering our facilities. Resources are available to our employees via the Company's benefits website, which include the latest news on COVID-19, steps to prevent illness and resources for mental health.

Our senior management team meets regularly to review the status of our operations, including the health and safety of our employees, and the impact of COVID-19 on our customers, suppliers and communities. Our ~~Board of Directors are updated regularly on the realized and expected impacts of COVID-19 and the Company's response to COVID-19, including steps to protect the workforce and cost-savings initiatives.~~ Additionally, the management team has benchmarked our efforts with peer companies to adopt best practices, improve our processes and share challenges that we are facing as we manage through the crisis.

~~Refer to the~~ ~~Liquidity and Capital Resources~~ ~~section of Management's Discussion and Analysis for information on the impact of COVID-19 on the liquidity of the Company.~~pricing.

2428

RESULTS OF OPERATIONS

Refer to Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations, of the Quarterly Report on Form 10-Q for the period ended April 2, 2021 for a discussion of changes for the earliest periods presented.

Net Sales ~~from Continuing Operations~~


		For the Three Months Ended							For the Three Months Ended
		April 2, 2021			April 3, 2020				April 1, 2022			April 2, 2021
		(in thousands)							(in thousands)
Organic sales		$	169,912		$	198,836
Sales of disposed businesses that did not qualify for discontinued operations		1,704			8,486
Net sales	Net sales	$	171,616		$	207,322		Net sales	$	158,048		$	171,616
$ change	$ change	(35,706)			40,888			$ change	(13,568)			(35,706)
% change	% change	(17.2)		%	24.6		%	% change	(7.9)		%	(17.2)		%

Sales of disposed businesses that did not qualify for discontinued operations								Sales of disposed businesses that did not qualify for discontinued operations	—			1,704
Organic sales								Organic sales	$	158,048		$	169,912
$ change								$ change	(11,864)
% change								% change	(7.0)		%

Net sales ~~decreased~~ for the three-month fiscal period ended April ~~2, 2021, as~~1, 2022 decreased when compared to the corresponding period in ~~2020,~~2021, primarily due to a ~~14.5%~~7.0% decrease in organic sales and ~~$6.8~~$1.7 million in lower sales due to the sale of our UKformer United Kingdom ("UK") Composites ~~business.~~business in early 2021. The decrease in organic sales was ~~primarily driven by $16.4~~attributable to $13.0 million in lower sales ~~under~~in our ~~safe~~Precision Products segment and ~~arm devices programs, a $12.5~~$8.6 million ~~decrease~~ in lower organic sales onat our ~~commercial business and general aviation programs and a $1.2 million decrease in sales on our defense programs, excluding safe and arm devices.~~Structures segment. These decreases were partially offset by ~~a $1.5 million~~an increase in sales ~~in industrial and other commercial programs. Sales under~~at our ~~medical programs remained relatively flat when compared to the corresponding period in 2020.~~Engineered Products segment. Foreign currency exchange rates relative to the U.S. dollar had ~~a favorable~~an unfavorable impact of ~~$1.7~~$2.0 million on net sales. See Segment Results of Operations and Financial Condition below for further discussion of segment net sales.

The table below summarizes the changes in organic net sales by product line for the three-month fiscal period ended April 2,1, 2022, compared to the corresponding period in 2021.

The decrease in sales on our safe and arm device programs was attributable to lower direct commercial sales of our JPF to foreign militaries, partially offset by higher sales under our JPF program with the USG and an increase in sales on our ATACMS fuzing contract.

The decrease in sales under our commercial business and general aviation programs was primarily attributable to lower sales volume of our commercial bearings products, driven by lower sales to Boeing and Airbus due to the impacts of COVID-19, and a decrease in sales under certain structures programs. These decreases, totaling $19.1 million, were partially offset by a K-MAX® aircraft delivery in the current period.

The decrease in sales under our defense programs, excluding safe and arm devices was primarily due to lower sales under the AH-1Z program, the Sikorsky BLACK HAWK helicopter program and a certain structures program. These decreases, totaling $4.8 million, were partially offset by higher sales on the A-10 program.

~~The increase in sales under our industrial and other commercial programs was primarily attributable to $1.3 million in higher sales volume of our bearings products.~~


Product Line	Increase (Decrease)	$ (in millions)	%
Defense	↓	$(11.4)	(26.7)%
Safe and Arm Devices	↓	$(4.3)	(10.3)%
Commercial, Business and General Aviation	↓	$(0.3)	(0.7)%
Medical	↑	$2.5	12.4%
Industrial	↑	$1.5	8.6%

Gross Profit ~~from Continuing Operations~~


		For the Three Months Ended							For the Three Months Ended
		April 2, 2021			April 3, 2020				April 1, 2022			April 2, 2021
		(in thousands)							(in thousands)
Gross profit	Gross profit	$	52,905		$	67,702		Gross profit	$	50,587		$	52,905
$ change	$ change	(14,797)			13,181			$ change	(2,318)			(14,797)
% change	% change	(21.9)		%	24.2		%	% change	(4.4)		%	(21.9)		%
% of net sales	% of net sales	30.8		%	32.7		%	% of net sales	32.0		%	30.8		%

Gross profit decreased for the three-month fiscal period ended April ~~2, 2021,~~1, 2022, as compared to the corresponding period in ~~2020.~~2021. This decrease was primarily attributable to ~~lower direct commercial~~the mix of JPF sales ~~of our JPF to foreign militaries~~in the quarter and lower sales and associated gross profit on our ~~commercial~~military bearings ~~products.~~products and our K-MAX® program. These decreases, totaling ~~$17.4~~$10.8 million, were partially offset by higher sales and associated gross profit ~~under~~on our ~~JPF program with the USG.~~springs, seals and contacts and commercial bearings products.

Gross profit as a percentage of sales increased for the three-month fiscal period ended April 1, 2022, as compared to the corresponding period in 2021, primarily due to improved performance on our seals, springs and contacts and bearings products. These increases were partially offset by cost growth on our K-MAX® program and certain structures programs.

Selling, General & Administrative Expenses (S,G&A) ~~from Continuing Operations~~

For the Three Months Ended
April 2,
2021 April 3,
2020
(in thousands)
S,G&A $ 44,991 $ 60,989
$ change (15,998) 19,038
% change (26.2) % 45.4 %
% of net sales 26.2 % 29.4 %


	For the Three Months Ended
	April 1, 2022			April 2, 2021
	(in thousands)
S,G&A	$	39,721		$	38,128
$ change	1,593			(15,201)
% change	4.2		%	(28.5)		%
% of net sales	25.1		%	22.2		%

S,G&A increased for the three-month fiscal period ended April 1, 2022, when compared to the corresponding period in 2021. This was primarily attributable to an increase in travel expenses and trade show costs as restrictions imposed to limit the spread of COVID-19 are lifting.

S,G&A decreased for the three-month ~~fiscal~~ period ended April 2, 2021 when compared to the corresponding period in 2020. This was primarily attributable to the absence of $8.5 million in Bal Seal acquisition costs and $1.8 million in third party costs associated with our efforts to reduce general and administrative expenses in the prior year, lower employee-related costs due to the cost reductions efforts implemented in the prior year, and a decrease in travel expenses and trade show costs due to restrictions imposed to limit the spread of COVID-19.

Costs from Transition Service Agreement

For the Three Months Ended
April 2,
2021 April 3,
2020
(in thousands)
Costs from transition services agreement $ 705 $ 4,140


	For the Three Months Ended
	April 1, 2022		April 2, 2021
	(in thousands)
Costs from transition services agreement	$	—	$	705

Upon closing the sale of our former Distribution business, the Company entered into a TSA with the buyer, pursuant to which the Company agreed to support the information technology ("IT"), human resources and benefits, tax and treasury functions of the Distribution business for six to twelve months. The buyer exercised ~~the~~an option to extend the support period for up to ~~a maximum of an~~one additional year for certain ~~information technology~~ services. ~~The buyer has~~During the ~~right to terminate individual services at any point over~~third quarter of 2021, the ~~renewal term~~TSA expired and ~~began to terminate certain services in 2020. Substantially~~ all services were completed as of the end of the ~~first quarter of 2021; however,~~period. As such, there were no costs incurred associated with TSA and no income earned from the TSA ~~is expected to be fully completed by~~in the ~~third quarter of 2021. We~~three-month fiscal period ended April 1, 2022. The Company incurred $0.7 ~~million and $4.1~~ million in costs associated with the TSA, ~~in the three-month fiscal periods ended April 2, 2021 and April 3, 2020, respectively. These costs~~which were partially offset by $0.5 ~~million and $3.0~~ million in income earned from the TSA in the three-month fiscal ~~periods~~period ended April 2, ~~2021 and April 3, 2020, respectively,~~2021. The income earned from the TSA was included below operating income in income from transition services agreement ~~which is below operating income~~ on the Company's Condensed Consolidated Statement of Operations.

~~Cost of Acquired Retention Plans~~Restructuring and Severance Costs

~~For the Three Months Ended~~

April 2,
2021

April 3,
2020

~~(in thousands)~~

~~Costs of acquired retention plans~~

—

~~5,703~~

Bal Seal's previous owner implemented employee retention plans prior to our acquisition in the first quarter of 2020. Upon closing, we funded $24.7 million of the purchase price into escrow accounts associated with these employee retention plans. As of the date of acquisition, Bal Seal had $1.9 million in costs accrued for these employee retention plans, and the remaining $22.8 million in compensation expense associated with these retention plans was incurred ratably throughout the year ended December 31, 2020. This amount and related interest was included in restricted cash on the Company's Consolidated Balance Sheets as of December 31, 2020. Eligible participants received an allocation of the escrow balance one year following the acquisition date, which is reflected in the Company's cash flows from operating activities for the three-month fiscal period ended April 2, 2021.


	For the Three Months Ended
	April 1, 2022		April 2, 2021
	(in thousands)
Restructuring and severance costs	$	169	$	1,352

2630

~~Restructuring and Severance Costs~~

For the Three Months Ended
April 2,
2021 April 3,
2020
(in thousands)
Restructuring and severance costs $ 1,352 $ 1,795

The Company continues to evaluate its costs with the objective of a lean organizational structure that provides a scalable infrastructure, which facilitates future growth opportunities. In the three-month fiscal period ended April ~~2, 2021,~~1, 2022, the Company incurred ~~$1.4~~$0.2 million in severance costs and costs associated with ~~these cost reduction efforts. These actions are expected~~the consolidation of facilities. Actions taken throughout 2021 and 2022 have started to ~~contribute~~generate savings in the first half of 2022, with total annualized cost savings of approximately ~~$3.7~~$8.3 million ~~which were factored in the Company's 2021 outlook.~~

Following the sale of our former distribution business, we announced that we would undertake a comprehensive review of our general and administrative functions in order to improve operational efficiency and to align our costs with our revenues. We identified information technology functions to be outsourced, workforce reductions and other reductions in certain general and administrative expenses which were completed in 2020 to support the cost savings initiative. These actions resulted in $1.3 million in severance costs in the three-month fiscal period ended April 3, 2020. Actions taken since the announcement of the cost savings initiative through 2020 are expected to contribute total annualized cost savings of approximately $18.2 million.

In addition to the severance costs associated with the cost savings initiative discussed above, we incurred $0.5 million in severance costs as we integrated the acquisition of Bal Seal in the year ended December 31, 2020.being realized by 2024.

Loss ~~(Gain)~~ on Sale of Business

For the Three Months Ended
April 2,
2021 April 3,
2020
(in thousands)
Loss (gain) on sale of business $ 234 $ (493)


	For the Three Months Ended
	April 1, 2022		April 2, 2021
	(in thousands)
Loss on sale of business	$	—	$	234

In 2020, we received approval from our Board of Directors to sell our UK Composites business. In the fourth quarter of 2020, we accrued a loss of $36.3 million on the anticipated sale. In the first quarter of 2021, we closed on a transaction to sell the UK Composites business. We recorded an additional loss of $0.2 million in the three-month fiscal period ended April 2, 2021 ~~associated with the sale.~~

During 2018, we sold our UK Tooling business to better position the Company for increased profitability. In 2019, we incurred a loss of $3.7 million associated with the write-off of note receivables recorded for the remaining amounts to be collected onwhen the sale ~~of the UK Tooling business as this balance~~ was ~~deemed not likely to be collected. In the three-month fiscal period ended April 3, 2020, we collected $0.5 million of the note receivables written off in 2019.~~finalized.

Operating Income ~~(Loss)~~


		For the Three Months Ended							For the Three Months Ended
		April 2, 2021			April 3, 2020				April 1, 2022			April 2, 2021
		(in thousands)							(in thousands)
Operating income (loss)		$	5,613		$	(4,422)
Operating income								Operating income	$	3,057		$	5,613
$ change	$ change	10,035			(16,791)			$ change	(2,556)			10,035
% change	% change	226.9		%	(135.8)		%	% change	(45.5)		%	226.9		%
% of net sales	% of net sales	3.3		%	(2.1)		%	% of net sales	1.9		%	3.3		%

~~The Company had operating~~Operating income ~~of $5.6 million~~decreased for the three-month fiscal period ended April ~~2, 2021,~~1, 2022, as compared to ~~an operating loss of $4.4 million in~~ the ~~comparable~~corresponding period in ~~2020. The change in operating income~~2021. This decrease was primarily driven by lower ~~costs related to~~operating income at the ~~TSA, the absence of Bal Seal acquisition costs~~Precision Products and ~~the costs associated with the acquired retention plans~~

~~incurred in the prior year and lower employee-related costs due to the cost reduction efforts implemented in the prior year.~~Structures segments. These changes were partially offset by higher operating income at the Engineered Products segment, lower ~~sales~~severance costs and ~~gross profit, as discussed above.~~the absence of costs related to the TSA. See Segment Results of Operations and Financial Condition below for further discussion of segment operating income.

Interest Expense, Net

For the Three Months Ended
April 2,
2021 April 3,
2020
(in thousands)
Interest expense, net $ 4,251 $ 3,247


	For the Three Months Ended
	April 1, 2022		April 2, 2021
	(in thousands)
Interest expense, net	$	2,481	$	4,251

Interest expense, net, generally consists of interest charged on our Credit Agreement, which includes a revolving credit facility, our convertible notes and the amortization of debt issuance costs, offset by interest income. ~~Interest~~The decrease in interest expense, net ~~increased~~ for the three-month fiscal period ended April ~~2, 2021. This increase~~1, 2022 was primarily attributable to ~~an increase in~~lower interest expense associated with our deferred compensation plan and $0.7 million in lower interest ~~income, partially offset by lower average borrowings.~~on our convertible notes, which was a result of the adoption of Accounting Standard Update ("ASU") 2020-06 on January 1, 2022. Refer to Note 2, Recent Accounting Standards, for further information on the adoption of ASU 2020-06.

Effective Income Tax Rate ~~from Continuing Operations~~

For the Three Months Ended
April 2,
2021 April 3,
2020
Effective income tax rate from continuing operations 2.5 % 52.1 %


	For the Three Months Ended
	April 1, 2022		April 2, 2021

Effective income tax rate	24.5	%	2.5	%

The effective income tax rate represents the combined federal, state and foreign tax effects attributable to pretax earnings ~~from continuing operations~~ for the period. The ~~decrease~~increase in the effective tax rate ~~from continuing operations~~ for the three-month fiscal period ended April ~~2, 2021, compared~~1, 2022 to the corresponding rate in the prior year was primarily caused by a discrete benefit ~~received~~recorded in the ~~current~~prior period related to the sale of ~~our~~the Company’s former UK Composites ~~business and the positive earnings in the current period versus a loss in the prior period. See Note 18,~~ ~~Income Taxes, for further information on the Company's valuation allowance for deferred tax assets.~~business.

Backlog

April 2,
2021 December 31,
2020
(in thousands)
Backlog $ 562,407 $ 631,236


	April 1, 2022		December 31, 2021
	(in thousands)
Backlog	$	705,023	$	700,923

Backlog ~~decreased~~increased during the first three months of ~~2021.~~2022. The ~~decrease~~increase was primarily attributable to ~~revenue recognized~~new orders for ~~deliveries of direct commercial JPF orders,~~our bearings ~~and medical~~ products and ~~work performed on our structures~~seals, springs and ~~legacy fuzing programs.~~contacts. These ~~decreases~~increases were partially offset by ~~orders~~revenue recognized on the JPF program with the USG and the Sikorsky UH-60 BLACK HAWK program and deliveries of our bearings products and springs, seals and contacts.

SEGMENT RESULTS OF OPERATIONS AND FINANCIAL CONDITION

Engineered Products Segment

Results of Operations


	For the Three Months Ended
	April 1, 2022			April 2, 2021
	(in thousands)
Net sales	$	81,452		$	71,779
$ change	9,673			(13,997)
% change	13.5		%	(16.3)		%

Operating income	$	11,042		$	4,906
$ change	6,136			(5,674)
% change	125.1		%	(53.6)		%
% of net sales	13.6		%	6.8		%

Net Sales

Net sales for 2022 increased compared to the corresponding period in 2021, driven by higher sales volume of our commercial and medical bearings products and springs, seals and contacts, including products used in medical implantables and defense and industrial applications. These improvements, totaling $13.1 million, were partially offset by lower sales volume of our defense bearings products.

Operating Income

Operating income for 2022 increased when compared to 2021, primarily due to higher sales and associated gross profit on our seals, springs and contacts and commercial bearings products. These increases in gross profit of $8.4 million were partially offset by lower sales volume and associated gross profit of our defense bearings products.

Precision Products Segment

Results of Operations


	For the Three Months Ended
	April 1, 2022			April 2, 2021
	(in thousands)
Net sales	$	47,549		$	60,533
$ change	(12,984)			(6,329)
% change	(21.4)		%	(9.5)		%

Operating income	$	3,409		$	13,053
$ change	(9,644)			(2,540)
% change	(73.9)		%	(16.3)		%
% of net sales	7.2		%	21.6		%

Net Sales

Net sales for 2022 decreased when compared to 2021, primarily due to the absence of a K-MAX® aircraft sale in the current period, the mix of JPF sales in the quarter and a decrease in sales on the Harpoon fuzing program.

Operating Income

Operating income for 2022 decreased when compared to 2021, primarily attributable to $8.0 million in lower gross profit, driven by the mix of JPF sales in the quarter and lower gross profit on our K-MAX® program, and higher research and development costs for the KARGO UAV unmanned aerial system.

Major Programs/Product Lines

Below is a discussion of significant changes in ~~our~~ major programs with the Precision Products segment during the first three months of ~~2021.~~2022. See our ~~2020~~2021 Form 10-K, including Item 1A, "Risk Factors", for a complete discussion of our major programs.

FMU-152 A/B – JPF

We manufacture the JPF, an electro-mechanical bomb safe and arming device, which allows the settings of a weapon to be programmed in flight. Sales of these fuzes can be direct to the ~~USAF,~~USG, Foreign Military Sales ("FMS") through the USG and ~~DCS~~Direct Commercial Sales (“DCS”) to foreign militaries that, although not funded by or sold through the USG, require regulatory approvals from the USG.

A total of ~~8,090~~6,020 fuzes were delivered to our customers during the first quarter of ~~2021.~~2022. We expect to deliver ~~30,000~~25,000 to ~~35,000~~30,000 fuzes in ~~2021.~~

2022. Total JPF backlog at April ~~2, 2021~~1, 2022 was ~~$184.5~~$76.1 million, ~~all~~down from $103.4 million at December 31, 2021. Of the $76.1 million in backlog at April 1, 2022, $3.3 million requires the receipt of ~~which has received required~~ export approvals, licenses or authorizations from the USG ~~allowing for~~before we are permitted to ship the ~~sale of these products~~fuzes outside of the United States. The timing and receipt of ~~future~~any such export

approvals, licenses, or authorizations are subject to political and geopolitical conditions ~~which could impact the timing and/or~~that are beyond our ~~ability to sell these products outside of the United States. Given the change in Administration,~~control. Therefore, there can be no assurance that this portion of our backlog ~~with appropriate approvals~~ will be ~~recognized due~~converted to ~~potential future policies to cease shipments to certain countries. As the Administration has indicated its desire to review the~~a firm sale ~~of defense products to two Middle Eastern countries, this has led to uncertainty on~~and, even if it is, the timing of ~~delivery of fuzes for one of our key customers. The outcome of~~ the ~~review remains uncertain; therefore, we elected to exclude the previously anticipated order from our outlook for 2021. Total JPF backlog at December 31, 2020 was $214.7 million.~~conversion is unknown.

Our JPF ~~- USG~~

~~Revenue for JPF USG programs is recognized over time when costs are incurred as work progresses on~~program continues to move through its product lifecycle, reflecting the program. The Company currently provides the FMU-152 A/B to the USAF, but the U.S. Navy currently utilizes a different fuze - the FMU-139. In 2015, NAVAIR solicited proposals for a firm fixed price production contract to implement improvements to the performance characteristicspreviously announced decision of the FMU-139 (such improved fuze having been designated the FMU-139 D/B), and, the USAF had stated that, if and when a contract is awarded and production begins, the funds associated with the FMU-152 A/B will be redirectedUnited States Air Force ("USAF") to the FMU-139 D/B. During the third quarter of 2015, the U.S. Navy announced that a competitor was awarded the contract for the FMU-139 D/B. In the event the FMU-139 D/B program proceeds as planned and the USAF redirects the funds associated with the FMU-152 A/Bmove to the FMU-139 D/B ~~our business, financial condition, results of operations and cash flows may be materially adversely impacted.~~(which we do not produce) as its primary fuze system. During the third quarter of 2019, our competitor announced that it received its first production order from the U.S. Navy to manufacture the FMU-139 D/B. Due to the complexity of this program and the pending status of the USAF's final decision to redirect funds to the FMU-139 D/B, the timing and magnitude of the impact on the Company's financial statements are not certain; however, the Company continues to see demand for the FMU-152 A/B. During the third quarter of 2020, we completed our pricing negotiations for Options 15 and 16 with the USG and we received an order under Option 15 with an expected value of approximately $57.3 million for the procurement of fuzes for 25 foreign militaries. In the first quarter of 2021, we began to satisfy the requirements under Option ~~15. We expect future orders~~15, which relates solely to the procurement of fuzes by 25 foreign militaries and has an expected value of approximately $57.3 million, and, in 2022, we began to satisfy the requirements under Option 16 which has an expected total value of approximately $43.0 million. Similar to ~~extend~~Option 15, this order relates solely to the procurement of fuzes by or in support of foreign militaries and does not include any sales to the USAF. Option 16 extends FMU-152 A/B ~~deliveries~~production into 2023. We have been advised by our customer that Option 16 will be the last order under our JPF contract with the USG. While we do not expect the close-out of our JPF contract with the USG to adversely impact our ability to continue to market the FMU-152 A/B directly to foreign militaries in direct commercial sales transactions, in the event the

foreign militaries move to the FMU-139 D/B, our financial condition and results of operations would be materially adversely impacted. We are currently in discussions with two Middle Eastern customers for one or more follow-on orders aggregating to a minimum of $45.0 million. The final value of these orders will be dependent on volume and pricing agreed upon in the completed contracts. If received, these orders would continue to extend the life of the program. DCS orders are subject to export approvals, licenses, or authorizations. The timing and receipt of any such export approvals, licenses, or authorizations are subject to political and geopolitical conditions that are beyond our control.

Structures Segment

Results of Operations


	For the Three Months Ended
	April 1, 2022			April 2, 2021
	(in thousands)
Net sales	$	29,047		$	39,304
$ change	(10,257)			(15,380)
% change	(26.1)		%	(28.1)		%

Operating (loss) income	$	(617)		$	320
$ change	(937)			(3,034)
% change	(292.8)		%	(90.5)		%
% of net sales	(2.1)		%	0.8		%

Net Sales

Net sales for 2022 decreased when compared to 2021, primarily due to the wind down of the AH-1Z program, timing of sales on the A-10 program, lower sales on certain composite programs and the absence of sales from our former UK Composites business, which was sold in early 2021. These decreases, totaling $11.5 million, were partially offset by higher sales on our programs with Rolls Royce.

Operating (Loss) Income

The Structures segment incurred an operating loss of $0.6 million for 2022 compared to operating income of $0.3 million in 2021. This change was primarily due to lower sales and associated gross profit on the AH-1Z program and our composite blade programs. These decreases in gross profit of $1.1 million were partially offset by higher gross profit on our Sikorsky Combat Rescue Helicopter program and a certain structures program with Boeing.

LIQUIDITY AND CAPITAL RESOURCES

Discussion and Analysis of Cash Flows

We assess liquidity in terms of our ability to generate cash to fund working capital requirements and investing and financing activities. Significant factors affecting liquidity include: cash flows generated from or used by operating activities, capital expenditures, investments in our business and programs, acquisitions, divestitures, dividends, availability of future credit, share repurchase programs, adequacy of available bank lines of credit, and factors that might otherwise affect the company's business and operations generally, as described under the heading “Risk Factors” and “Forward-Looking Statements” in Item 1A of Part I of our ~~2020~~2021 Form 10-K.

~~COVID-19~~

We anticipate that the disruptions and delays resulting from the spread of COVID-19 and the measures instituted by governments and businesses to mitigate its spread could impact our liquidity in the next twelve months. At April 2, 2021, the Company had $120.7 million of cash on our Condensed Consolidated Balance Sheet. We are closely managing our daily cash flows to optimize our liquidity position. We also continue to closely monitor the collectability of our receivables from commercial aerospace customers as we recognize there may be delays in payments due to the impacts of COVID-19 on our customers. As of the date of this filing, we do not believe there has been any material impact on the collectability of these receivables. In addition to the daily reviews of collections and payables, management meets with our business units on a regular basis to review liquidity.

As of the date of this filing, we believe the Company has adequate liquidity due to the cash we have on hand, the bank financing we have available to us and the other actions we have taken to enhance financial flexibility and reduce the potential impact of the pandemic on the Company.

2934

A summary of our consolidated cash flows ~~from continuing operations~~ is as follows:


		For the Three Months Ended							For the Three Months Ended
		April 2, 2021		April 3, 2020		2021 vs. 2020			April 1, 2022		April 2, 2021		2022 vs. 2021
		(in thousands)							(in thousands)
Total cash provided by (used in):	Total cash provided by (used in):							Total cash provided by (used in):
Operating activities	Operating activities	$	(2,415)	$	(55,442)	$	53,027	Operating activities	$	(1,017)	$	(2,415)	$	1,398
Investing activities	Investing activities	(8,100)		(303,780)		295,680		Investing activities	(6,453)		(8,100)		1,647
Financing activities	Financing activities	(4,684)		182,878		(187,562)		Financing activities	(4,035)		(4,684)		649

Free Cash Flow (a)	Free Cash Flow (a)							Free Cash Flow (a)
Net cash used in operating activities		$	(2,415)	$	(55,442)	$	53,027
Net cash provided by (used in) operating activities								Net cash provided by (used in) operating activities	$	(1,017)	$	(2,415)	$	1,398
Expenditures for property, plant and equipment	Expenditures for property, plant and equipment	(4,678)		(5,559)		881		Expenditures for property, plant and equipment	(6,877)		(4,678)		(2,199)
Free cash flow	Free cash flow	$	(7,093)	$	(61,001)	$	53,908	Free cash flow	$	(7,894)	$	(7,093)	$	(801)

(a) Free Cash Flow, a non-GAAP financial measure, is defined as net cash (used in) provided by operating activities less expenditures for property, plant and equipment, both of which are presented in our Condensed Consolidated Statements of Cash Flows. See Management’s Discussion and Analysis of Financial Condition and Results of Operations—Non-GAAP Financial Measures for more information regarding Free Cash Flow.

Net cash used in operating activities was ~~$2.4~~$1.0 million for the three-month fiscal period ended April ~~2, 2021,~~1, 2022, a ~~$53.0~~$1.4 million improvement to cash used in the comparable period in ~~2020.~~2021. This change was largely driven by the ~~collection of payments on outstanding receivables, more specifically the receipt of approximately $53.0 million in payments on JPF DCS receivables, the~~ absence of ~~a $10.0 million pension contribution and lower material receipts on the K-MAX® program in the current period. These changes were partially offset by~~ approximately $25.1 million in nonrecurring payments to eligible participants of Bal Seal's employee retention plans ~~implemented~~paid in the prior ~~to our acquisition~~year and the timing of accounts payable cash disbursements, partially offset by the timing of collection of payments on outstanding receivables, more specifically significant receipts on JPF DCS receivables in ~~2020.~~the prior year, higher material receipts on the K-MAX® program and lower net earnings in the current period.

Net cash used in investing activities was ~~$8.1~~$6.5 million for the three-month fiscal period ended April ~~2, 2021, $295.7~~1, 2022, $1.6 million less than cash used in the comparable period in ~~2020.~~2021. This change was primarily attributable to the cash ~~used to acquire Bal Seal~~impact of the sale of our former UK Composites business in the prior ~~year.~~year, partially offset by higher capital expenditures.

Net cash used in financing activities was ~~$4.7~~$4.0 million for the three-month fiscal period ended April ~~2, 2021, compared to net~~1, 2022, relatively flat with cash ~~provided by financing activities of $182.9 million~~used in the comparable period in 2020. This change was primarily due to higher net borrowings under our revolving credit facility in the prior year in preparation for the potential impact of the COVID-19 pandemic, partially offset by lower purchases of treasury shares in the current period.2021.

We anticipate a variety of items will have an impact on our liquidity during the next twelve months, in addition to ~~the impacts of the COVID-19 pandemic and~~ our working capital requirements. These could include one or more of the following:

•the matters described in Note ~~14,~~15, Commitments and Contingencies, in the Notes to Consolidated Financial Statements, including the cost of existing environmental remediation matters;

•contributions to our qualified pension plan and Supplemental Employees’ Retirement Plan (“SERP”);

•deferred compensation payments to officers;

•interest payments on outstanding debt;

•income tax payments;

•costs associated with acquisitions and corporate development activities;

•finance and operating lease payments;

•capital expenditures;

•research and development expenditures;

•repurchase of common stock under ~~the 2015 Share Repurchase Program;~~share repurchase programs;

•payment of dividends;

•costs associated with the start-up of new programs; and

•the timing of payments and the extension of payment terms by our customers.

Financing Arrangements

We continue to rely upon bank financing as an important source of liquidity for our business activities, including acquisitions. We believe this, when combined with cash generated from operating activities, will be sufficient to support our anticipated future cash requirements; however, we may decide to borrow additional funds or raise additional equity capital to support other business activities, including potential future acquisitions. We regularly monitor credit market conditions to identify potential

issues that may adversely affect, or provide opportunities for, the securing and/or advantageous pricing of additional financing, if any, that may be necessary to continue with our growth strategy and finance working capital requirements. Refer to Note 14, Debt, in the Notes to the Consolidated Financial Statements, included in Item 8, Financial Statements and Supplementary Data, of the ~~2020~~2021 Form 10-K for further information on our Financing Arrangements.

Convertible Notes

During May 2017, we issued $200.0 million aggregate principal amount of convertible senior unsecured notes due May 2024 (the "2024 Notes") pursuant to an indenture, dated May 12, 2017, between the Company and U.S. Bank National Association, as trustee (as amended by the First Supplemental Indenture thereto, dated July 15, 2019, the "Indenture"). In connection therewith, we entered into certain capped call transactions that cover, collectively, the number of shares of the Company's common stock underlying the 2024 Notes. The 2024 Notes bear 3.25% interest per annum on the principal amount, payable semiannually in arrears on May 1 and November 1 of each year, beginning on November 1, 2017. The 2024 Notes will mature on May 1, 2024, unless earlier repurchased by the Company or converted. We will settle any conversions of the 2024 Notes in cash, shares of the Company's common stock or a combination of cash and shares of common stock, at our election.

The sale of our former Distribution business in the third quarter of 2019 was deemed to be a "Fundamental Change" and a "Make-Whole Fundamental Change" pursuant to the terms and conditions of the indenture governing the 2024 Notes. As a result, the sale triggered the right of the holders of our 2024 Notes to require us to repurchase all of the 2024 Notes, or any portion thereof that is a multiple of $1,000 principal amount on September 27, 2019. The aggregate principal amount of the 2024 Notes validly tendered and not validly withdrawn was $0.5 million, representing approximately 0.25% of all outstanding notes. Holders of such notes received the repurchase price equal to 100% of the principal amount of the 2024 Notes being purchase, plus accrued and unpaid interest.

We incurred $7.4 million of debt issuance costs in connection with the sale of the 2024 Notes, which ~~was~~were allocated between the debt and equity components of the ~~instrument.~~instrument at issuance. Of the total amount, $0.7 million was recorded as an offset to additional paid-in capital. The balance, $6.7 million, was recorded as a contra-debt balance and iswas being amortized over the term of the 2024 Notes. As a result of the adoption of ASU 2020-06, the amount recorded to additional paid-in capital was reclassified to retained earnings in the cumulative effect adjustment. The remaining balance of debt issuance costs is being amortized over the term of the convertible notes. Total amortization expense for the three-month fiscal periods ended April ~~2, 2021~~1, 2022 and April ~~3, 2020~~2, 2021 was $0.2 million in both periods. Refer to Note 2, Recent Accounting Standards, for further information on the adoption and impacts of ASU 2020-06.

Credit Agreement

On December 13, 2019, the Company closed an amended and restated $800.0 million Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A., as Administrative Agent and as Collateral Agent. The Credit Agreement matures on December 13, 2024 and consists of revolving commitments of $800.0 million. Capitalized terms used but not defined within this discussion of the Credit Agreement have the meanings ascribed thereto in the Credit Agreement, which with amendments is included as Exhibit ~~10.39~~10.43 to our ~~2020~~2021 Form 10-K.

We incurred $3.6 million of debt issuance costs in connection with the amendment and restatement of the Credit Agreement. Total amortization expense for three-month fiscal periods ended April 2, 2021 and April 3, 2020 was $0.2 million in both periods.

Interest rates on amounts outstanding under the Credit Agreement are variable based on LIBOR. The LIBOR benchmark has been the subject of national, international, and other regulatory guidance and proposals for reform. In July 2017, the U.K. Financial Conduct Authority announced that it intends to stop persuading or compelling banks to submit rates for calculation of LIBOR after 2021. In November 2020, the ICE Benchmark Association announced its intention to delay the timeline for the retirement of LIBOR until mid-2023. These reforms may cause LIBOR to perform differently than in the past, and LIBOR may ultimately cease to ~~exist after 2021.~~exist. Alternative benchmark rate(s) may replace LIBOR and could affect the Company's debt securities, derivative instruments, receivables, debt payments and receipts. An alternative rate may create additional basis risk for market participants as an alternative index is utilized alongside LIBOR. Key regulatory authorities have requested that banks cease entering into new contracts that use USD LIBOR as a reference rate, and do not permit new or existing non-USD LIBOR borrowings, by no later than December 31, 2021. Additionally, the Alternative Reference Rates Committee has recommended replacing USD LIBOR with the Secured Overnight Financing Rate (“SOFR”), which is calculated by short-term repurchase agreements. There can be no guarantee that SOFR will become widely used, or that any alternatives may or may not be developed.

In 2021, the Company amended its Credit Agreement to move its LIBOR benchmark for non-USD borrowings to other non-USD benchmark rates. Future USD borrowings under our current Credit Agreement will continue be based on LIBOR. At this time, it is not possible to predict the effect of any changes to LIBOR, ~~any~~the phase out of LIBOR or any establishment of alternative benchmark rates. Any new benchmark rate will likely not replicate LIBOR exactly, which could impact our contracts that terminate after 2023. There is uncertainty about how applicable law, the courts or the Company will address the replacement of LIBOR with alternative rates on variable rate retail loan contracts and other contracts that do not include alternative rate fallback provisions. ~~In addition, any changes to~~

3136

~~benchmark rates may have an uncertain impact on our cost of funds and our access to the capital markets, which could impact our liquidity, financial position or results of operations.~~

No amounts were outstanding under the revolving credit facility in the first quarter of ~~2021;~~2022; therefore, the interest rate for the period was 0%. We are required to pay a quarterly commitment fee on the unused revolving loan commitment amount at a rate ranging from 0.150% to 0.250% per annum, based on the Senior Secured Net Leverage Ratio. Fees for outstanding letters of credit range from 1.125% to 1.625%, based on the Senior Secured Net Leverage Ratio. There were no bank borrowings during the three-month fiscal period ended April ~~2, 2021, compared to total average bank borrowings of $111.9 million for~~1, 2022 and the year ended December 31, ~~2020.~~2021.

The following table shows the amounts available for borrowing under the Company's revolving credit facility:


		April 2, 2021		December 31, 2020			April 1, 2022		December 31, 2021
In thousands	In thousands					In thousands
Total facility	Total facility	$	800,000	$	800,000	Total facility	$	800,000	$	800,000
Amounts outstanding, excluding letters of credit	Amounts outstanding, excluding letters of credit	—		—		Amounts outstanding, excluding letters of credit	—		—
Amounts available for borrowing, excluding letters of credit	Amounts available for borrowing, excluding letters of credit	800,000		800,000		Amounts available for borrowing, excluding letters of credit	800,000		800,000
Letters of credit under the credit facility(1)(2)	Letters of credit under the credit facility(1)(2)	152,475		165,373		Letters of credit under the credit facility(1)(2)	91,892		92,646
Amounts available for borrowing	Amounts available for borrowing	$	647,525	$	634,627	Amounts available for borrowing	$	708,108	$	707,354

Amounts available for borrowing subject to EBITDA, as defined by the Credit Agreement(3)	Amounts available for borrowing subject to EBITDA, as defined by the Credit Agreement(3)	$	346,880	$	363,997	Amounts available for borrowing subject to EBITDA, as defined by the Credit Agreement(3)	$	378,803	$	409,914

(1) The Company has entered into standby letters of credit issued on the Company's behalf by financial institutions, and directly issued guarantees to third parties primarily related to advances received from customers and the guarantee of future performance on certain contracts. Letters of credit generally are available for draw down in the event the Company does not perform its obligations.

(2) Of these amounts, ~~$146.2~~$86.3 million letters of credit relate to a ~~certain~~ JPF DCS contract ~~in both periods.~~in the periods ended April 1, 2022 and December 31, 2021.

(3) Amounts available for borrowing subject to EBITDA reflect the minimum borrowing capacity under EBITDA, subject to adjustments.

We incurred $3.6 million of debt issuance costs in connection with the amendment and restatement of the Credit Agreement. Total amortization expense for the three-month fiscal periods ended April 1, 2022 and April 2, 2021 was $0.2 million in both periods.

Other Sources/Uses of Capital

~~Advance Payments~~Letters of Credit

~~In 2018, we received $97.2 million in advance payments, which relate to $146.2~~Of the standby letters of credit under our credit facility, $86.3 million in letters of a credit ~~for~~relate to a JPF DCS contract, including the offset agreement. In the event that we default on the contract and we are unable to fulfill our contractual obligations, our customer has the ability to draw on the letters of credit.

Pension Plans

Management regularly monitors pension plan asset performance and the assumptions used in the determination of our benefit obligation, comparing them to actual performance. We continue to believe the assumptions selected are valid due to the long-term nature of our benefit obligation.

~~We contributed $10.0 million~~No contributions are expected to be made to the qualified pension plan ~~subsequent to the end of the first quarter and~~during 2022. The Company contributed $0.1 million to the SERP through the end of the first quarter of ~~2021. No further contributions are expected to be made to the qualified pension plan during 2021. We plan~~2022 and plans to contribute an additional ~~$2.6~~$0.4 million to the SERP in ~~2021.~~2022. For the ~~2020~~2021 plan year, wethe Company contributed $10.0 million to the qualified pension plan and ~~$0.5~~$2.7 million to the SERP.

Effective December 31, 2015, our qualified pension plan was frozen with respect to future benefit accruals. Under USG Cost Accounting Standard (“CAS”) 413, we must calculate the USG’s share of any pension curtailment adjustment calculated resulting from the freeze. Such adjustments can result in an amount due to the USG for pension plans that are in a surplus position or an amount due to the contractor for plans that are in a deficit position. During the fourth quarter of 2016, we accrued a $0.3 million liability representing our estimate of the amount due to the USG based on our pension curtailment calculation, which was submitted to the USG for review in December 2016. We have maintained our accrual at $0.3 million as of April ~~2, 2021.~~1, 2022. There can be no assurance that the ultimate resolution of this matter will not have a material adverse effect on our results of operations, financial position and cash flows.

3237

Share-based Arrangements

Stock Repurchase Plans

On April 20, 2022, we announced that our Board of Directors approved a share repurchase program ("2022 Share Repurchase Program") authorizing the repurchase of up to $50.0 million of the common stock, par value $1.00 per share, of the Company. We repurchase shares to offset the annual issuance of shares under our employee stock plans, but the timing and actual number of shares repurchased will depend on a variety of factors including stock price, market conditions, corporate and regulatory requirements, capital availability and other factors, including acquisition opportunities. This plan replaces the authorization approved in April 2015.

NON-GAAP FINANCIAL MEASURES

Management believes the non-GAAP (Generally Accepted Accounting Principles) measures used in this report provide investors with important perspectives into our ongoing business performance. We do not intend for the information to be considered in isolation or as a substitute for the related GAAP measures. Other companies may define the measures differently. We define the non-GAAP measures used in this report and other disclosures as follows:

Organic Sales

Organic Sales is defined as "Net Sales" less sales derived from acquisitions completed or businesses disposed of that did not qualify for accounting as a discontinued operation during the previous twelve months. We believe that this measure provides management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, which can obscure underlying trends. We also believe that presenting Organic Sales separately provides management and investors with useful information about the trends impacting our operations and enables a more direct comparison to other businesses and companies in similar industries. Management recognizes that the term "Organic Sales" may be interpreted differently by other companies and under different circumstances.


Organic Sales from continuing operations (in thousands)
Organic Sales (in thousands)						Organic Sales (in thousands)
		For the Three Months Ended					For the Three Months Ended
		April 2, 2021		April 3, 2020			April 1, 2022		April 2, 2021
Net sales	Net sales	$	171,616	$	207,322	Net sales	$	158,048	$	171,616
Acquisition sales	Acquisition sales	—		—		Acquisition sales	—		—
Sales of disposed businesses that did not qualify for discontinued operations	Sales of disposed businesses that did not qualify for discontinued operations	1,704		8,486		Sales of disposed businesses that did not qualify for discontinued operations	—		1,704
Organic Sales	Organic Sales	$	169,912	$	198,836	Organic Sales	$	158,048	$	169,912

Free Cash Flow

Free Cash Flow is defined as GAAP “Net cash provided by (used in) operating activities” in a period less “Expenditures for property, plant & equipment” in the same period. Management believes Free Cash Flow provides an important perspective on our ability to generate cash from our business operations and, as such, that it is an important financial measure for use in evaluating the Company's financial performance. Free Cash Flow should not be viewed as representing the residual cash flow available for discretionary expenditures such as dividends to shareholders or acquisitions, as it may exclude certain mandatory expenditures such as repayment of maturing debt and other contractual obligations. Management uses Free Cash Flow internally to assess overall liquidity.

CONTRACTUAL OBLIGATIONS AND OFF-BALANCE SHEET ARRANGEMENTS

There have been no material changes outside the ordinary course of business in our contractual obligations or off-balance sheet arrangements during the first three months of ~~2021.~~2022. See our ~~2020~~2021 Form 10-K for a discussion of our contractual obligations and off-balance sheet arrangements.

3338

CRITICAL ACCOUNTING ESTIMATES

Preparation of the Company’s financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Management believes the most complex and sensitive judgments, because of their significance to the Consolidated Financial Statements, result primarily from the need to make estimates about the effects of matters that are inherently uncertain. Management’s Discussion and Analysis and the Notes to Consolidated Financial Statements in the Company’s ~~2020~~2021 Form 10-K describe the critical accounting estimates and significant accounting policies used in preparing the Consolidated Financial Statements. Actual results in these areas could differ from management’s estimates.

RECENT ACCOUNTING STANDARDS

Information regarding recent changes in accounting standards is included in Note 2, Recent Accounting Standards, of the Notes to Condensed Consolidated Financial Statements in this report.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no significant changes in the Company’s exposure to market risk during the first three months of ~~2021.~~2022. See the Company’s ~~2020~~2021 Form 10-K for a discussion of the Company’s exposure to market risk.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We have carried out an evaluation, under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Act of 1934, as amended, as of April ~~2, 2021.~~1, 2022. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based upon our evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of April ~~2, 2021,~~1, 2022, our disclosure controls and procedures were effective.

Internal Controls over Financial Reporting

There was no change to our internal control over financial reporting that occurred during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to affect, our internal control over financial reporting.

3439

PART II

Item 1. Legal Proceedings

General

From time to time, as a normal incident of the nature and kinds of businesses in which the Company and its subsidiaries are, and were, engaged, various claims or charges are asserted and legal proceedings are commenced by or against the Company and/or one or more of its subsidiaries. Claimed amounts may be substantial but may not bear any reasonable relationship to the merits of the claim or the extent of any real risk of court or arbitral awards. We record accruals for losses related to those matters that we consider to be probable and that can be reasonably estimated. Gain contingencies, if any, are recognized when they are realized and legal costs generally are expensed when incurred.

We evaluate, on a quarterly basis, developments in legal proceedings that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. Our loss contingencies are subject to substantial uncertainties, however, including for each such contingency the following, among other factors: (i) the procedural status of the case; (ii) whether the case has or may be certified as a class action suit; (iii) the outcome of preliminary motions; (iv) the impact of discovery; (v) whether there are significant factual issues to be determined or resolved; (vi) whether the proceedings involve a large number of parties and/or claims in multiple jurisdictions or jurisdictions in which the relevant laws are complex or unclear; (vii) the extent of potential damages, which are often unspecified or indeterminate; and (viii) the status of settlement discussions, if any, and the settlement postures of the parties. Because of these uncertainties, management has determined that, except as otherwise noted below, the amount of loss or range of loss that is reasonably possible in respect of each matter described below (including any reasonably possible losses in excess of amounts already accrued), is not reasonably estimable.

While it is not possible to predict the outcome of these matters with certainty, based upon available information, management believes that all settlements, arbitration awards and final judgments, if any, which are considered probable of being rendered against us in legal proceedings and that can be reasonably estimated are accrued for at April ~~2, 2021.~~1, 2022. Despite this analysis, there can be no assurance that the final outcome of these matters will not have a material adverse effect on our business, financial condition, results of operations or cash flows.

As of April ~~2, 2021,~~1, 2022, neither the Company nor any of its subsidiaries was a party, nor was any of its or their property subject, to any material pending legal proceedings, other than ordinary routine litigation incidental to the business of the Company and its subsidiaries. Additional information relating to certain of these matters is set forth in Note ~~14,~~15, Commitments and Contingencies, of the Notes to Condensed Consolidated Financial Statements.

Environmental Matters

The Company and its subsidiaries are subject to numerous U.S. federal, state and international environmental laws and regulatory requirements and are involved from time to time in investigations or litigation of various potential environmental issues concerning activities at our facilities or former facilities or remediation as a result of past activities (including past activities of companies we have acquired). From time to time, we receive notices from the U.S. Environmental Protection Agency or equivalent state or international environmental agencies that we are a potentially responsible party under the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as the “Superfund Act”) and/or equivalent laws. Such notices assert potential liability for cleanup costs at various sites, which may include sites owned by us, sites we previously owned and treatment or disposal sites not owned by us, allegedly containing hazardous substances attributable to us from past operations. While it is not possible to predict the outcome of these proceedings, in the opinion of management, any payments we may be required to make as a result of all such claims in existence at April ~~2, 2021,~~1, 2022, will not have a material adverse effect on our business, financial condition and results of operations or cash flows.

Item 1A. Risk Factors

Investors should carefully review and consider the information regarding certain factors that could materially affect our business, results of operations, financial condition and cash flows as set forth under Item 1A. “Risk Factors” in our ~~2020~~2021 Form 10-K. We do not believe there have been any material changes to the risk factors previously disclosed in our ~~2020~~2021 Form 10-K, but we may disclose changes to such factors or disclose additional factors from time to time in future filings with the SEC. Additional risks and uncertainties not presently known to us or that we currently believe not to be material may also adversely impact our business, results of operations, financial position and cash flows.

3540

FORWARD-LOOKING STATEMENTS

This report contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others: (i) risks related to Kaman's performance of its obligations under the transition services agreement entered into in connection with the sale of our former Distribution business and UK Composites business and disruption of management time from ongoing business operations relating thereto; (ii) changes in domestic and foreign economic and competitive conditions in markets served by the Company, particularly the defense, commercial aviation and industrial production markets; ~~(iii)~~(ii) changes in government and customer priorities and requirements (including cost-cutting initiatives, government and customer shut-downs, the potential deferral of awards, terminations or reductions of expenditures to respond to the priorities of Congress and the Administration, or budgetary cuts resulting from Congressional actions ~~including the elimination of Overseas Contingency Operations funding,~~ or automatic sequestration); ~~(iv)~~(iii) the global economic impact of the COVID-19 pandemic; ~~(v)~~(iv) changes in geopolitical conditions in countries where the Company does or intends to do business; ~~(vi)~~(v) the successful conclusion of competitions for government programs (including new, follow-on and successor programs) and thereafter successful contract negotiations with government authorities (both foreign and domestic) for the terms and conditions of the programs; ~~(vii)~~(vi) the timely receipt of any necessary export approvals and/or other licenses or authorizations from the USG; ~~(viii)~~(vii) timely satisfaction or fulfillment of material contractual conditions precedents in customer purchase orders, contracts, or similar arrangements; ~~(ix)~~(viii) the existence of standard government contract provisions permitting renegotiation of terms and termination for the convenience of the government; ~~(x)~~(ix) the successful resolution of government inquiries or investigations relating to our businesses and programs; ~~(xi)~~(x) risks and uncertainties associated with the successful implementation and ramp up of significant new programs, including the ability to manufacture the products to the detailed specifications required and recover start-up costs and other investments in the programs; ~~(xii)~~(xi) potential difficulties associated with variable acceptance test results, given sensitive production materials and extreme test parameters; ~~(xiii)~~(xii) the receipt and successful execution of production orders under the Company's existing USG JPF contract, including the exercise of all contract options and receipt of orders from allied militaries, but excluding any next generation programmable fuze programs, as all have been assumed in connection with goodwill impairment evaluations; ~~(xiv)~~(xiii) the continued support of the existing K-MAX® helicopter fleet, including sale of existing K-MAX® spare parts inventory and the receipt of orders for new aircraft sufficient to recover our investments in the K-MAX® production line; ~~(xv)~~(xiv) the accuracy of current cost estimates associated with environmental remediation activities; ~~(xvi)~~(xv) the profitable integration of acquired businesses into the Company's operations; ~~(xvii)~~(xvi) the ability to recover from cyber-based or other security attacks, information technology failures or other ~~disruptions, including the December 2020 Bal Seal incident; (xviii)~~disruptions; (xvii) changes in supplier sales or vendor incentive policies; ~~(xix)~~(xviii) the ability of our suppliers to satisfy their performance ~~obligations; (xx)~~obligations, including any supply chain disruptions; (xix) the effects of price increases or decreases; ~~(xxi)~~(xx) the effects of pension regulations, pension plan assumptions, pension plan asset performance, future contributions and the pension freeze, including the ultimate determination of the USG's share of any pension curtailment adjustment calculated in accordance with CAS 413; ~~(xxii)~~(xxi) future levels of indebtedness and capital expenditures; ~~(xxiii)~~(xxii) the continued availability of raw materials and other commodities in adequate supplies and the effect of increased costs for such items; ~~(xxiv)~~(xxiii) the effects of currency exchange rates and foreign competition on future operations; ~~(xxv)~~(xxiv) changes in laws and regulations, taxes, interest rates, inflation rates and general business conditions; ~~(xxvi)~~(xxv) future repurchases and/or issuances of common stock; ~~(xxvii)~~(xxvi) the occurrence of unanticipated restructuring costs or the failure to realize anticipated savings or benefits from past or future expense reduction actions; ~~(xxviii)~~(xxvii) the ability to recruit and retain skilled employees; and ~~(xxix)~~(xxviii) other risks and uncertainties set forth herein and in our ~~2020~~2021 Form 10-K.

Any forward-looking information provided in this report should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

3641

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information about purchases of common stock by the Company during the three-month fiscal period ended April ~~2, 2021:~~1, 2022:

Period Total Number
of Shares
Purchased (a) Average
Price Paid
per Share Total Number of
Shares Purchased as
Part of a Publicly
Announced Plan (b)
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plan (in thousands)
January 1, 2021 - January 29, 2021 — $ — — $2,168
January 30, 2021 - February 26, 2021 — $ — — $2,168
February 27, 2021 - April 2, 2021 6,792 $ 50.72 — $2,168
Total 6,792 —


Period	Total Number of Shares Purchased (a)	Average Price Paid per Share		Total Number of Shares Purchased as Part of a Publicly Announced Plan (b)	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plan(c) (in thousands)
January 1, 2022 - January 28, 2022	129	$	44.72	—	$2,168
January 29, 2022 - February 25, 2022	332	$	42.53	—	$2,168
February 26, 2022 - April 1, 2022	8,442	$	43.41	—	$2,168
Total	8,903			—

(a) During the first quarter of ~~2021~~2022 the Company purchased ~~6,792~~8,903 shares in connection with employee tax withholding obligations as permitted by our equity compensation plans, which are SEC Rule 16b-3 qualified compensation plans. These were not purchases under our publicly announced program.

(b) On April 29, 2015, the Company announced that its Board of Directors approved a $100.0 million share repurchase program. At April 1, 2022, $2.2 million remained available for repurchase under this authorization.

(c) On April 20, 2022, the Company announced that its Board of Directors approved a $50.0 million share repurchase program. This plan replaces the authorization approved in April 2015 (refer to note b above). For additional information, see "Item 7.2. Management's Discussion and Analysis of Financial Condition and Results of Operations -- Liquidity and Capital Resources -- Other Sources/Uses of Capital" in ~~the Company’s Annual Report on~~this Form ~~10-K~~10-Q for the ~~year~~three-month fiscal period ended ~~December 31, 2020.~~April 1, 2022.

3742

Item 6. Index To Exhibits


10.1	Form of Restricted Share Agreement under the ~~Kaman Corporation~~ Amended and Restated Kaman Corporation 2013 Management Incentive Plan, for awards granted on or after February 22, ~~2021~~2022 (incorporated by reference to Exhibit ~~10.1~~10.7 to the ~~Company's Current~~Company’s Annual Report on Form ~~8-K dated February 26,~~10-K for the fiscal year ended December 31, 2021, File No. 001-35419).*	Previously Filed
10.2	Form of Performance Stock Unit Award Agreement under the ~~Kaman Corporation~~ Amended and Restated Kaman Corporation 2013 Management Incentive Plan, for awards granted on or after February 22, 2022 (incorporated by reference to Exhibit ~~10.2~~10.9 to the ~~Company's Current~~Company’s Annual Report on Form ~~8-K dated February 26,~~10-K for the fiscal year ended December 31, 2021, File No. 001-35419).*	~~Previously Filed~~
~~10.3~~	Amendment No. 4 to the Executive Employment Agreement between the Company and Neal J. Keating (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated April 16, 2021, File No. 001-35419).*	Previously Filed
31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14 under the Securities Exchange Act of 1934	Filed Herewith
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14 under the Securities Exchange Act of 1934	Filed Herewith
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Filed Herewith
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Filed Herewith
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101

* Management contract or compensatory plan.

3843

SIGNATURES

Kaman Corporation and Subsidiaries

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

KAMAN CORPORATION

Registrant

Date:

May ~~4, 2021~~2, 2022

/s/ Ian K. Walsh

By:

Ian K. Walsh

Chairman, President and

Chief Executive Officer

Date:

May ~~4, 2021~~2, 2022

/s/ ~~Robert D. Starr~~James G. Coogan

By:

~~Robert D. Starr~~James G. Coogan

~~Executive~~Senior Vice President and

Chief Financial Officer

3944